Immunopathogenesis of a Spectrum of Inflammatory Lung Diseases Induced by Experimental Reovirus Infection by Bellum, Stephen Clifford
Medical University of South Carolina 
MEDICA 
MUSC Theses and Dissertations 
1998 
Immunopathogenesis of a Spectrum of Inflammatory Lung 
Diseases Induced by Experimental Reovirus Infection 
Stephen Clifford Bellum 
Medical University of South Carolina 
Follow this and additional works at: https://medica-musc.researchcommons.org/theses 
Recommended Citation 
Bellum, Stephen Clifford, "Immunopathogenesis of a Spectrum of Inflammatory Lung Diseases Induced 
by Experimental Reovirus Infection" (1998). MUSC Theses and Dissertations. 103. 
https://medica-musc.researchcommons.org/theses/103 
This Dissertation is brought to you for free and open access by MEDICA. It has been accepted for inclusion in 
MUSC Theses and Dissertations by an authorized administrator of MEDICA. For more information, please contact 
medica@musc.edu. 
Immunopathogenesis of a Spectrum of Inflammatory Lung Diseases Induced by 
Experimental Reovirus Infection 
Stephen Clifford Bellum 
A dissertation submitted to the faculty of the Medical University of South Carolina in 
partial fulfillment of the requirement for the degree of Doctor of Philosophy in the 
College of Graduate Studies 




Steven D. London, D.D.S., Ph.D. 
Ch . 
Russell A. Harley, M.D. 
~\.~~\L 
Lucille London, Ph.D. 
H · liv/~-
Maria TrojanO~Ska, Ph.D. 
, f .. .".,...---
t:t/;/!; kr I~ 
11 
ACKNOWLEDGEMENTS 
Thank you Steven and Lucille for providing me with this opportunity. Your 
guidance and the stimulating environment you have created have helped me to organize 
my curiosity and to think critically. Theseare skills that have given me great confidence 
in my abilities and enabled me to proceed to another level of training. I will always 
regard my graduate experience as a period of tremendous personal and academic growth. 
Also, I know I am fortunate that the other members of my committee, Drs. 
Trojanowska, Tyor, and Harley were at all times generously helpful and interested in my 
project. The technical advice and scientific insight that you were able to dispense to me, 
by benefit of your expertise helped me to ask interesting and important questions. I look 
forward to future opportunities for discussions. 
None of us are able to successfully reach our goals by working alone. My 
colleagues during the time of my graduate work; Damir Hamamdzic, Sanja Altman-
Hamamdzic, Allison Stack, Amy Thompson, Elizabeth Majeski, Taetia Phillips-Dorsette, 
and Sherry Crowe all exposed me to a diversity of personalities and experiences that have 
and will continue to be a part of my life. In particular, I would like to especially 
111 
acknowledge Elizabeth and Sanja for their contributions to the initial characterization of 
the reovirus-induced inflammatory lung response in neonatally thymectomized CBA/J 
mice. Also, thank you Damir for the many thoughtful discussions that I have had with 
you throughout my graduate career. 
I thank my family for granting me unyielding, loving support during my graduate 
career. My parents, Clifford and Shirlyn, and my sisters, Karen and Laura sacrificially 
invested themselves emotionally into each of my obstacles and successes. Furthermore, I 
acknowledge my maternal grandmother, Mazie Daniels, and my paternal grandfather 
Clifford Bellum Sr. who have supported me throughout this experience with love and 
prayer. Finally, my maternal grandfather, "Shorty", and my paternal grandmother, Mabel 
Bellum, who are deceased, also were and will remain important influences in the shaping 
of my life and of my interests. 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS 11 
LIST OF FIGURES VI11 
LIST OF ABBREVIATIONS .......... ........ ... ............ ... ... ............. xi 
ABSTRACT 
CHAPTERS 
1 General Introduction and Review O/the 
Literature 
2 Materials And Methods 
• Animals and Housing 
• Inoculation Protocol 
• Virus 
• Histology 
• Electron Microscopy 
• Antibodies 
• Immunohistochemistry 
• Titration of Infectious Virions 
• RNA Preparation 















3 Respiratory Reovirus llL-Induced Follicular Bronchiolitis: A 
Model for the Study of Lung Inflammation in the context ofl 
the Mucosal Immune System 
• Introduction 
• Results 




Reovirus IlL-Infected CD-I Mice ............. 36 
Replication and Clearance of Reovirus IlL 
from the Lungs of Infected CD-I Mice ............. 41 
Histopathological Alterations in Reovirus IlL 
Infected CD-I Mouse Lungs . . . . . . . . . . . . . 45 
Immunohistochemical Localization of 
Lymphocyte Populations in Reovirus IlL 
Infected CD-I Mouse Lungs . . . . . . . . . . . . . 50 
• Discussion 52 
4 Respiratory Reovirus llL-Induced Bronchiolitis Obliterans 
v 
Organizing Pneumonia: A Model for the Study of Bronchoalveolar Fibrosis 
................................ 58 
• Introduction 59 
• Results 
Respiratory Reovirus IlL Infection of CBAlJ 
Mice Induces Intraluminal Fibrotic Lesions 
61 
... 62 
Histopathological Analysis of the Temporal 
Development of BOOP Lesions in CBAlJ Mice ... 63 
Ultrastructural Characterization of BOOP 
Lesions ... 70 
5 
6 
Immunohistochemical Localization of Reovirus 
Associated Proteins in Reovirus IlL infected 
Lungs ... ............................ 72 
Clearance of Reovirus IlL from the Lungs of 
Infected CBAlJ Mice ... ....................... ..... 74 
• Discussion 
Respiratory Reovirus IlL-Induced Acute Respiratory Distress 
Syndrome: A Model of Acute Bronchoalveolar Inflammation 
• Introduction 
• Results 
Respiratory Reovirus IlL Infection Alternatively 




in a Subset of CBAlJ Mice . . . . . . . . . . . ... 84 
ARDS Development in CBAlJ Mice Following Reovirus 
Inoculation is Dose Dependent . . . . . . . . . . . . .. 84 
Histopathological Characterization of the Lungs of 
Neonatally Thymectomized CBAlJ Mice Following 
Respiratory Reovirus Infection 
• Discussion 










LIST OF FIGURES 
Chapter One General Introduction and Review of the Literature 
Figure 1.1 Schematic of FB, BOOP, and ARD 15 
Figure 1.2 Schematic of Intra-alveolar Inflammation ..................... 20 
Figure 1.3 Schematic of Reovirus ..................... 23 








A Model for the Study of Lung Inflammation in the Context of the 
Mucosal Immune System 
An india ink colored test inoculum is widely distributed 
in the lung . . . . .. .. . . . . . . . . . . . . . 36 
Body and Lung Weights of reovirus IlL-infected CD-I 
Mice ..................... 37 
Gross Pathology of reovirus IlL-infected lungs .... . . . . . . . . . . . . . . . . . 41 
Detection of reovirus replication in CD-I lungs ..................... 41 
Detection of reovirus replication in C3H lungs ..................... 42 
Infectious virus titers of the lungs of reovirus IlL-infected 
CD-I mice .. .. .. .. .. .. .. .. . .. .. 43 
Histological characterization of the lung of 
reovirus IlL infected CD-I mice 45 
VIll 
Figure 3.8 Histological characteristics of the lymphoid plasmocytic 
reaction to reovirus IlL infection in CD-I lungs ..................... 47 
Figure 3.9 Histological characterization of the reovirus IlL-induced 
inflammatory infiltrate ..................... 48 
Figure 3.10 Immunohistochemical analysis of the reovirus IlL-induced 
cellular infiltrate .. .. .. .. .. . .. . . .. .. .. 50 
Chapter Four Respiratory Reovirus ilL-Induced Bronchiolitis Obliterans 











Histological characterization of a well-formed BOOP lesion....... 61 
Temporal analysis of the pulmonary inflammatory response 
and fibrotic reaction in CBAlJ mice 64 
Further histologic characterization of the cellullar response 
induced by reovirus IlL in CBA/J mice . . . . . . . . . . 66 
Histologic characterization of alterations in lung architechture 
after reovirus IlL inoculation in CBAlJ mice . . . . . . . . .. 67 
Histologic characterization of lung associated lymphoid 
tissue hyperplasia after reovirus IlL inoculation in 
CBA/J mice 
Ultrastructural characterization of a BOOP lesion 
Immunohistochemical analysis of reovirus IlL -encoded 
proteins after i.n. inoculation in CBAlJ mice 




CBA/J mice .. .. .. .. . . 74 
Infectious virus titers of the spleen and Peyer's patches of 








Respiratory Reovirus ilL-Induced Acute Respiratory Distress 
Syndrome: Amodel for the Study of the Immunopathogenesis of 
Acute Bronchoalveolar Inflammation 
Respiratory Reovirus IlL Infection Induces ARDS in CBA/J 
Mice 
Histologic Characterization of ARDS in CBA/J 
Mice 
Flow Cytometric Analysis of CD3 expression by thymectomized 
85 
86 
and normal CBA/J mice peripheral lymph nodes. . . . . . . . . . . . . . . . . .. 90 
Histological characterization of the reovirus IlL induced 
inflammatory infiltrate and intraluminal fibrosis in 
thymectomized CBAlJ mice ................... 91 
Histological characterization of BOOP in thymectomized 

























List of Abbreviations 
Acute Respiratory Distress Syndrome 
Bronchus Associated Lymphoid Tissue 
Bronchiolitis Obliterans Organizing Pneumonia 
Cytotoxic T Lymphocyte 
Diffuse Alveolar Damage 
Extracellular Matrix 
Follicular Bronchiolitis 
01 ycosaminogl ycans 
Gastrointestinal Tract 





Lung Associated Lymph Node 
Major Histocompadability Complex 
NeoNatally Thymectomized 
Pulmonary Artery 
Phosphate Buffered Saline 
Plaque Forming Unit 
Peyer's Patches 
Usual Interstitial Pneumonia 
Verhoeff Van Oieson 
Xl 
Absract 
Inflammatory lung diseases cause a significant amount of morbidity and mortality. However, the 
mechanisms that control the initiation and resolution of pulmonary inflammatory responses have 
not been well-elucidated. Histopathological data suggests that the lung responds with a similar 
pattern of inflammation to diverse range of injurious stimuli. In order to investigate the 
immunopathogenesis of lung inflammation, a series of in vivo models of lung inflammation were 
generated in CBAlJ and CD-I mice by respiratory reovirus IlL infection. Using this approach, it 
was observed in CBAlJ mice that a relatively low titer of reovirus IlL induced a pattern of 
intraluminal fibrosis in the bronchoalveolar compartment of the lung that is characteristic of the 
disorder bronchiolitis obliterans organizing pneumonia (BOOP). When higher titers of reovirus 
IlL were used to inoculate CBA/J mice, most animals developed acute respiratory distress 
syndrome CARDS), which is characterized by widespread vascular endothelial and respiratory 
epithelial cell damage. Conversely, the pulmonary response of CD~ 1 mice to respiratory reovirus 
IlL was not acute or fibrotic, but instead was characterized by a bronchiocentric, lymphocytic 
cellular infiltrate that recapitulates the disorder follicular bronchiolitis (FB). FB was also 
described as a simultaneous component of the inflammatory response in CBA/J mice in addition 
to BOOP and ARDS. Collectively the models of reovirus IlL-induced FB, BOOP, and ARDS 
represent a spectrum of inflammatory lung disorders that are generated by one agent, thus 
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General Introduction 
The cellular and molecular interactions among pulmonary inflammatory and resident 
parenchymal cells following injury or infection of the lung are incompletely understood 
(Colby 1997). Histopathological observations of lung inflammation (including fibrosis) 
indicate that the lung responds with a similar pattern of inflammation to wide range of 
inflammatory stimuli as diverse as connective tissue disorders, lung transplantation, bone 
transplantation, exposure to toxic agents, and pathogenic infections (Epler 1992; Wright, et 
al. 1992; Wells and du Bois 1993; Myers and Colby 1993; Kanda, et al. 1997). The 
following investigations of the immunopathogenesis of lung inflammation are focused on 
three models of human lung disorders that primarily affect the distal airways, which include 
the small airways and air spaces of the lung. These surfaces collectively compose the 
largest interface that the body maintains with the outside environment (Pabst 1995). 
However, very little is known about the interactions of the respiratory epithelium with 
infiltrating inflammatory cells following injury or infection of the distal regions of the lung. 
Respiratory reovirus IlL infection of selected mouse strains has been used to recapitulate 
Follicular Bronchiolitis (FB), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and 
Acute Respiratory Distress Syndrome (ARDS). FB, the first -of these models to be 
described, is a lymphoid-proliferative disorder that primarily affects the small conducting 
airways of the lung, but does not usually result in alterations to the architecture of the lung 
(Yousem 1985; Kinane 1993). The second model is of BOOP, which is characterized by 
the presence of intraluminal fibrotic lesions in the small airways of the lung and in the 
alveolar spaces (Epler 1985). BOOP is also typically associated with a lympoid-
proliferative component like that observed with FB (Epler 1995). Lastly, respiratory 
reovirus IlL infection is also used to generate a model of ARDS, a severe inflammatory 
disease of the lung characterized by widespread, massive alveolar epithelial and vascular 
endothelial cell damage (Luce 1998). 
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FB, BOOP, and ARDS are disorders that primarily affect the distal regions of the 
lung, which include small airways (bronchioles) and air spaces (alveoli) as well as the 
intervening interstitial and vascular tissue. Bronchiolar lumens are characterized by a 
mucosal epithelial lining and then moving from the lumen towards the adventitia, a basement 
membrane, a thin layer lamina propria, an elastic tissue membrane, a layer of smooth muscle, 
and an adventitial connective tissue layer that is associated with the surrounding alveolar and 
perivascular interstitium (Colby 1998). The bronchioles lead into the alveolar ducts, which 
communicate directly with the alveolar air spaces (Wang 1988). In humans, as the 
bronchioles transition into alveolar ducts a number of air spaces may be found along the 
walls of the bronchioles (Wang 1988). These bronchioles are referred to as respiratory 
bronchioles; however, respiratory bronchioles are not typically found in rodents (Pabst 
1992). A schematic representing the cellular and anatomic features of FB, BOOP, and 
ARDS is shown in Figure 1.1. 
The lung alveolar epithelium covers a large surface area (Simon and Paine 1995). 
Two types of cells comprise the alveolar epithelium, Type I cells and Type II cells (Crapo 
1982). Type I cells are characterized by an extremely attenuated cytoplasm that is spread 
over a relatively large area (Simon and Paine 1995). Approximately 93% of the alveolar 
epithelium surface area is composed of Type I cells (Simon and Paine 1995). A basement 
membrane underlies the alveolar epithelium and allows capillary endothelial cells to be 
juxtaposed to Type I cells (Crapo 1982). The other 7% of the alveolar surface is covered by 
Type II cells (Saffiotti 1996). Contrary to the thin, attenuated morphology of Type I cells, 
Type II cells are compact and cuboidal (Simon and Paine 1995). Each Type II cell covers 
only 3% of the basal lamina surface area as does each Type I cell, but Type II cells are 
progenitor cells for Type I cells and can differentiate into Type I cells in order to replace 
damaged epithelium (Simon and Paine 1995). However, Type I cells represent a tenninally 
differentiated cell type and are not able to revert to a Type II state (Simon and Paine 1995). 
While Type I cells primary function is to mediate the exchange of gases between the 
• = lymphocyte 




alveolar lumen and the vasculature, Type II cells are more involved in the synthesis and 
recycling of factors that maintain normal lung physiology (Rooney 1994). The 
progression of lung inflammation to fibrosis appears to involve intimate cell-to-cell contact 
between the alveolar epithelium and fibroblasts in the lung interstitium (Rhodes, et ale 1989; 
Adamson, et al. 1988). The failure of type II cells to differentiate quickly enough to 
alveolar type I cells (type I) in order to replace damaged respiratory epithelium has been 
proposed as an important event leading to intra-alveolar fibrosis (Rhodes, et al. 1989; 
Adamson, et al. 1988). In addition, a rat model of silicosis-induced interstitial lung fibrosis 
showed that type II produce Transforming Growth Factor (TGFJ3)-I, a potent stimulator of 
fibroblasts to secrete collagen and precedes extra cellular matrix (ECM) proteins (Williams, 
et ale 1993). There have also been investigations performed demonstrating that lung 
fibroblasts do not just passively respond to inflammatory and fibrogenic signals, but that 
they can also regulate their own proliferation via the secretion of Platelet-Derived Growth 
Factor (PDGF)A , Fibroblast Growth Factor (FGF)-2, and Insulin Growth Factor (IGF)-1 
(Rapolee and Werb 1992; Story, et al. 1993; Shoji, et ale 1990). 
Investigations into the mechanisms that control inflammation In the lung have 
traditionally focused on professional inflammatory cells (macrophages, lymphocytes, 
eosinophils, and neutrophils) which gather in the alveolar spaces following lung injury or 
pathogenic infection (Simon and Paine 1995). In general, organized lymphoid tissue is 
usually absent in normal adult human or murine lungs (Colby 1998). However, under 
conditions of chronic inflammation lymphoid follicles characteristic of FB may develop 
along bronchioles as a component of the mucosal immune response (Yousem 1991). Lung 
parenchymal cells, particularly epithelial cells and fibroblasts, have become increasingly 
recognized for their role in the regulation of the inflammatory response under pathologic 
conditions (Simon and Paine 1995). Type II cells have been shown to be capable of 
processing and presenting antigen to T lymphocytes (Schneeberger 1986). The role of type 
II cells as antigen presenting cells is further demonstrated by the fact that isolated type II 
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cells can stimulate allogeneic T lymphocytes to proliferate in a mixed lymphocyte reaction 
(Annstrong 1992). 
Type IT cells are also able to participate in the regulation of inflammatory reactions 
by secreting inflammatory cytokines such as, Tumor Necrosis Factor (TNF)a and 
Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF) (Piguet, et ale 1993; Nash, et 
ale 1993; Tazi, et ale 1993). Messenger RNA transcripts for Macrophage Inflammatory 
Factor (MIP)-2, a potent chemoattractant of neutrophils and lymphocytes has also been 
detected in the cytoplasm of type II cells shortly after exposure of the lung epithelium to a-
quartz in rats (Driscoll, et al. 1996). In general peptide mediators belonging to the cytokine 
and growth factor families are being increasingly recognized as important regulators of 
inflammation and fibrosis in the lung (Jordana, et ale 1993; Kumar and Lykke 1995). It is 
through an elaborate, organized cytokine network that all the cell types involved In a 
pulmonary inflammatory response are able to communicate (Jordana, et ale 93; Kumar and 
Lykke 95). Although many investigations into pulmonary cytokine production have 
demonstrated alveolar macrophages to be the primary source of cytokines in the lung, more 
recent studies suggest that fibroblasts, alveolar epithelial, endothelial, neutrophils, 
eosinophils, and lymphocytes are also important sources of cytokines (Kita, et al. 1991; 
Zhang, et ale 1995). Early inflammatory events occurring within hours after injury to the 
lung epithelium have been associated with the expression of Interleukin (IL-l)a and IL-l~, 
IL-8, Monocyte Chemotactic Protein (MCP), and TNFa. (Jordana, et al. 1993; Zhang, et ale 
1995). Upregulation of TNFa has been reported within hours after lung injury in 
experimental models of pulmonary fibrosis generated by exposure of the lung to the toxic 
chemotherapeutic agent bleomycin or to silica dust (Piguet, et al. 1990). TNFa has also 
been strongly associated with the transformation of a pulmonary inflammatory response 
into a fibrotic reaction (Piguet, et al. 1990; Jordana, et al. 1993; Zhang, et al. 1995). 
However, fibrosis cannot be initiated solely by the administration of recombinant TNFa 
suggesting that multiple factors are required in vivo for inflammatory and fibrotic processes 
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to proceed (Piguet, et ale 1990). Clinical studies of human lung inflammation as well as the 
bleomycin model of lung injury have also been used to show' that TGF(3 ECM deposition 
(Zhang, et al. 1995). 
Initial experiments to define the pulmonary cytokine network focused on the release 
of cytokines into the cell free bronchoalveolar lavage (BAL) fluid of mice that were 
inoculated intratrachearly with influenza virus (Holt, et ale 1986; Hou, et al. 1992). These 
experiments demonstrated an early increase in a number of cytokines including IL-l u, IL-
1(3, TNFu, Interferon (IFN)y and GM-CSF but did not find an increase in the T cell 
cytokines, IL-2, IL-3 and IL-4 (Holt, et al. 1986; Hou, et al. 1992). An evaluation of the 
cytokine mRNA expression by in situ hybridization analysis of cells obtained from both 
lung associated lymph nodes (LALN) and lungs following primary influenza virus infection 
demonstrated that the pulmonary T -lymphocyte response to influenza is detected first in the 
lymph nodes and then later in the lungs following the emigration of effector T cells from the 
LALN to the lungs (Becker, et al. 1991). CD8+ T cells were shown to express mRNA for 
IFNy and TNF(3, whereas mRNA for IL-4 and IL-I0 was more prevalent in CD4+ cells 
(Becker, et al. 1991). In addition, y/5 T cells predominately expressed IL-2, IL-4, and IFN-
y (Becker, et al. 1991; Hou, et ale 1995). The frequency of cytokine-secreting cells from the 
BAL cells of influenza virus infected mice demonstrated numerous IL-2, IL-4 and IFNy 
secreting cells with fewer TNF or IL-I0 secreting cells (!konen, et al. 1994). Depletion of 
CD4+ and CD8+ cells significantly decreased the frequency of IL-2 and IL-4 secreting cells 
(Ikonen, et al. 1994). In contrast, cells obtained from the lung associated lymph nodes did 
not produce IL-4, IL-5 or TNF while IL-2, IL-I0 and INFy expression were prominent 
(Jackson, et al. 1987). 
Respiratory Syncytial Virus (RSV) infection of the lung has also been used to study 
immune responses at respiratory surfaces. It was shown in vitro that RSV initially causes 
an abortive infection of alveolar macrophages and the production of TNFu, IL-6, and IL-8, 
all of which may modulate the inflammatory responses to the virus (Joel and Chanana 
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1985). Additionally, RSV induced TNFa and IL-l, but not IL-6 and IL-8 mRNA 
expression from bronchial epithelial cells, suggesting that cytokines produced by RSV-
infected alveolar macrophages may be important in modulating the inflammatory response 
to RSV than directly interfering with viral infection or replication (Joel and Chanana 1985). 
With RSV immunization, it was shown that the pattern of cytokine expression observed 
after i.n. application was dependent on the form of RSV used (Jones and Ada 1987; Jung, et 
al. 1993). The most predominant cytokine found in the lungs after foonaHn inactivated 
(FI)-RSV inoculation was IL-4 (Jones and Ada 1987; Jung, et af. 1993). However, 
intranasal immunization with viable RSV predominately induced a THI like pattern (Jones 
and Ada 1987). The effect of cytokine depletion was evaluated upon restimulation with 
either FI-RSV or infection with RSV (Jung, et al. 1993). Simultaneous depletion of both 
IL-4 and IL-I0 completely abrogated the pulmonary histopathology in FI-RSV-immunized 
mice, while depletion of a-2 or IFNy had no effect suggesting that FI-RSV inoculation 
primes for the TH2 cytokines (IL-4, IL-I0) (Jung, et al 1993). In addition, treatment of 
mice with IL-4 at the time of immunization with FI-RSV reduced clinical illness after a live 
viral challenge that was associated with an augmented CTL response (Kaltreider, et al. 
1987). Taken together, these results suggest that different subpopulations of lymphocytes 
can be activated by different forms of RSV and the subpopulation-of lymphocytes that are 
activated can be selectively modulated by anti-cytokine treatment prior to re-stimulation 
(Kaltreider, et al. 1987; Jung, et al. 1993). These experiments collectively demonstrate the 
complexity of the inflammatory response of respiratory cell populations, which have been 












Figure 1.3: Schematic of reovirus 
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within 15 minutes after adsorption (Silverstein and Dales 1968). Then the reovlrus-
containing endosomes fuse with lysosomes within an hour (Silverstein and Dales 1968). 
Proteolysis of the outer capsid then takes about 2 to 3 hours (Silverstein and Dales 1968). 
Once the virus particles are uncoated, transcription and replication of new progeny genomes 
for all 10 genes and translation of new viral proteins can occur by 10 hours post infection 
(Zweerink and Joklik 1970). By that timepoint most of the protein production in the host 
cell is for viral proteins (Zweerink and Joklik 70). An alternative pathway may also exist for 
reovirus adsorption and penetration that allows reovirus to bypass receptor mediated 
endocytosis and lysosome proteolysis (Borsa, et al. 1982; Nibert, et al. 1996). This occurs 
when proteolytic lysis outside of the cell causes the partial uncoating of the viral particle, 
fonning what is referred to as an intennediate subviral particle (ISVP) (Borsa, et al. 1982; 
Nibert, et al. 1996). The ISVPs have then shown to be able to directly enter the host cell 
and initiate transcription without interacting with lysosomes (Borsa, et al. 1982, Nibert, et al. 
1996). Following the translation of viral proteins and the transcription and replication of 
new progeny genome segments, assembly of new virus particles occurs by a mechanism 
that is still not clear, but it only results in approximately 1 infectious reovirus particle out of 
a 100 assembled virions (Nibert, et al. 1996). Normally, the new reovirus particles are 
released from the host cell lytically; however, depending on the· cell type reovirus may 
persistently infect the host cell (Ahmed and Fields 1982; Taber, et al. 1976). 
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CHAPTER 2 
Materials and Methods 
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Animals and housing 
The following mice were used for investigations relating to this thesis: Sixteen to 
eighteen gram female outbred CD-l mice (Charles Rivers Laboratories, Wilmington, MA); 
4 to 5 week old female Balb/C (H-2d), C3H (H-2k), and CBAlJ (H-2k) mice (Jackson 
Laboratories, Bar Harbor, rvrn); and 4 to 5 week old CBAlJ that were neonatally 
thymectomized 4 days after birth (surgery performed by Jackson Laboratories, Bar Harbor, 
IvIE). All mice were maintained in micro-isolator cages under specific pathogen-free 
conditions in a BL-2 facility. Cages were housed in a HEPA-filtered animal isolator clean 
room (Nuaire Inc, Plymouth, MN). 
Inoculation protocol 
Animals were anesthetized with an intraperitoneal (Lp.) injection of 0.15 cc (CBAlJ 
mice were inoculated with 0.1 cc because they appeared to be more sensitive to the 
anesthetic) of 20% Ketamine and 2% PromAce (Vetalar 100mglml and Acepromazine 
Maleate 10mglml respectively; Ayerst Laboratories, New York, NY). CD-I, Balb/C, and 
C3H strains of mice were then inoculated intranasally (i.n.) with 1 x 107 PFU of reovirus 
IlL in 30 J..lI (15 J..lI in each nostril) of sterile injectable grade 0.9% NaCI (Baxter Healthcare 
Corp., Deerfield, IL). Control animals received only the saline solution or the inactivated 
reovirus IlL by the identical inoculation procedure. CBAlJ and neonatally thymectomized 
CBAlJ mice were inoculated intranasally (i.n.) with reovirus IlL (1 x 106 PFU or 1 x 107 
PFU as indicated in the figure legends) in 30 J..lI of 0.9% NaCI (15 J..lI in each nostril) 
(Baxter Healthcare Corp., Deerfield, IL). Reovirus IlL at 3.3 x 108 PFU/ml 0.9% NaCI in a 
P-60 petri dish was inactivated by exposure to an ultraviolet (UV) light source (30W /G30; 
Philips Electronics, Holland) placed 15 cm away for 15 minutes. Control animals received 
either 1 x 106 PFU of UV-inactivated virus or only the saline solution by the identical 
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inoculation procedure. Reovirus IlL-inoculated mice of all strains were kept physically 
isolated from all other experimental and control mice. 
Virus 
Reovirus IlL was originally obtained from Dr. W. Joklik (Duke University School of 
Medicine, Durham, NC). Third-passage gradient-purified stocks were obtained by 
recloning and amplifying parental stocks with a L-929 fibroblast cell line as previously 
described (Rubin, et al. 1985). Following the purification of new stocks, infectious viral 
titers were obtained by limiting dilution on L-929 monolayers. 
Histology 
Hematoxylin and Eosin staining was performed on 4 micron sections of lungs fixed 
overnight in 10% neutral buffered formalin and embedded in paraffin. Tissue sections were 
prepared and stained by the Department of Pathology and Laboratory Medicine, Medical 
University of South Carolina. 
Electron Microscopy 
Cross sectional areas of lung lobes were examined for areas of pathologic change using a 
dissecting microscope. 1 nun3 blocks were cut and processed by standard techniques using 
2% aqueous osmic acid followed by dehydration through graded alcohols and propylene 
oxide. 0.5 J.1m sections were obtained from Epoxy embedded blocks and were placed on 
glass slides and stained with Toluidine blue The sections were examined by light 
microscopy and appropriate areas were sectioned at 800 Angstroms, placed on copper grids, 
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and stained with uranyl acetate-lead citrate contrast stains. The grids were examined with an 
Hitachi H-7000 transmission electron microscope. 
Antibodies 
The following monoclonal antibodies were used in this study: RA3-6B2, anti-B220; 
MI/70.15, anti CDllb (Mac-I); YTS 169.4, anti-CD8a; XMG1.2, anti IFNy; BVD-24G2, 
anti IL-4 (Caltag, So. San Francisco, CA); HI29.19, anti-CD4 (Gibco, Gaithersburg, MD); 
and reovirus specific rabbit serum (a gift from Dr. Donald Rubin; Vanderbilt University, 
Nashville, TN); 
Immunohistochemistry 
Animals were sacrificed with an i.p. injection of 0.2 cc Sodium Nembutal (50 
mglml; Abbott Laboratories, No. Chicago, IL). The lungs were inflated in situ with OCT 
compound (TissueTek II, Miles Laboratories Inc., Naperville, IL) by tracheal intubation, 
removed, suspended in additional OCT compound, and snap-frozen in liquid nitrogen. The 
tissues were stored at -70oC. Five micron sequential sections were collected on poly-L-
lysine (Sigma, St. Louis, MO) treated slides and immediately fixed for 10 minutes in 95% 
ethanol at room temperature. After two five-minute washes in PBS, the sections were 
blocked for 20 minutes with a solution of 2% normal serum blocking solution (serum from 
the species the secondary Ab was made) (Vector Laboratories, Burlingame, CA) and 0.5% 
nonfat dried milk in PBS. A 1:50 dilution (in blocking solution) of the primary antibody 
was added and incubated for 45 minutes, except for XMG 1.2, anti IFNy, and BVD-24G2, 
anti IL-4, which- were incubated overnight at 40 C. After two five-minute PBS washes, the 
biotinylated secondary Ab (anti-IgG of the species in which the primary Ab was made) 
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(VectorLaboratories,Burlingame,CA)diluted 1:100 in blocking solution was added to the 
slides and incubated for 30 minutes. After two additional five-minute PBS washes, the 
tissues were treated for 30 minutes with a 1 % solution of hydrogen peroxide (Sigma, St. 
Louis, MO) in methanol to quench endogenous peroxidase activity. Following two 
additional five-minute washes the slides were incubated for 30 minutes with the solution 
containing the avidin-biotin-peroxidase complex (ABC kit; Vector Laboratories, 
Burlingame, CA) which was prepared and used according to manufacturer's instructions. 
Diaminobenzidine (Sigmafast DAB tablets; Sigma, St. Louis, MO) was prepared according 
to the manufacturer's instructions and allowed to react with the peroxidase-labeled tissue for 
20 minutes. After two, one minute rinses in distilled water, the tissue was hematoxylin 
counter stained (Gill's #1; Baxter, McGaw Park, IL), cleared and dehydrated by successive 
gradations through 70%, 95%, and 100% ethanol followed by a final passage in xylene. 
The slides were mounted with Accu Mount 60 (Stephens Scientific; Riverdale, NJ). 
Titration of infectious virions 
Freshly harvested lungs without the associated lymph nodes were removed and 
freeze-thawed three times in 2 mls of 0.5% gelatin (Difco Laboratories, Detroit, MI) 
dissolved in PBS (gel-saline) followed by homogenization for 45 seconds with a 
microprobe tip of a Virsonic 475 sonicator (Virtis, Gardner, NY). Serial dilutions of the 
lung homogenate in gel-saline were used in a standard plaque assay on L-929 cell 
monolayers in 6-well tissue culture dishes (Becton Dickinson Labware, Lincoln Park, NJ) 
as previously described (Rubin, et al. 1985). 
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RNA Preparation 
Total cellular RNA was isolated from freshly harvested lungs by guanidinium 
denaturation according to manufacturer's instructions utilizing RNazol (Tel-Test Laboratory, 
Inc., Friendswood, TX) for RNA work performed in chapters 3 and 4 and Tri-Reagent 
(Molecular Research Center, Inc. Cincinnati, OH) for RNA work performed in Chapter 5. 
RNA Blot Analysis 
RNA was subjected to electrophoresis through a 1 % agarose, 7% formaldehyde gel 
followed by transfer to nitrocellulose membrane (Schleicher & Schuell, Keene, NH) by 
capillary blotting with lOX sse buffer. Nitrocellulose membranes were prehybridized in 
phosphate buffer (500 mM Na2HP04, pH 7.2, 1 mM EDTA, pH 8.0, 7% SDS, 1 % bovine 
serum albumin) at 650 C for 60 minutes. Incubation was continued for 12-15 hrs. in the 
same solution containing the [32P]-labeled probe created by nick translation (Promega, 
Madison, WI) of a full length reovirus serotype 3/Strain Dearing M3 gene inserted into a 
pUC vector (gift from Dr. Joklik, Duke University, Durham, NC-). The hybridized blots 
were washed twice at 650 C in buffer containing 40 mM Na2HP04, pH 7.5, 1 % SDS and 1 
mM EDTA, pH 8.0 for 60 min. The blots were dried and exposed to FUJI RX film at -
700 C with a Kodak Lanex Regular intensifying screen for 18 hours. 
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CHAPTER 3 
Respiratory Reovirus IlL Induced Follicular Bronchiolitis: 
A Model for the Study of the Lung Inflammation in the 
context of the Mucosal Immune System 
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Introduction 
The mucosal immune system provides the first line of defense against pathogens 
which invade at the wet epithelial surfaces of the body (Croitoru and Bienenstock 1994). 
These sites include the gastrointestinal (01), respiratory, and urogenital tracts as well as 
other wet mucosal surfaces of the body (phillips-Quagliata and Lamm 1994). The 
predominance of immunoglobulin A (lgA) antibodies at mucosal surfaces has allowed the 
definition of an interrelated immune response which operates among these mucosal sites 
(Tomasi 1992). Thus, immunization at one mucosal site frequently results in the generation 
of antigen-specific IgA antibodies at other mucosal sites as opposed to systemic sites 
(Phillips-Quagliata and Lamm 1994). The linking of mucosal sites by lymphocytes which 
preferentially recirculate to mucosal areas defines the common mucosal immune system. 
Since specific IgA antibodies at mucosal surfaces have been correlated with protection 
against a number of mucosally related pathogens (Murphy 1994; Underdown and Schiff 
1986), knowledge concerning the details of immunity generated at mucosal surfaces is 
critical for the control of many human and animal pathogens. 
The GI tract has served as a paradigm for the study of mucosal immunity since this 
site is thought to be important in the generation of many mucosal immune responses and a 
number of distinct lymphoid components can be obtained from this tissue (Kiyono, et ale 
1992). Lymphoid populations of the GI tract include lymphocytes contained within the PP 
that line the wall of the intestine, lymphocytes contained within the epithelium, and 
lymphocytes contained within the lamina propria connective tissue underlying the gut 
epithelium (Kiyono, et ale 1992). Specialized epithelial cells (microfold, M cells) present 
within the dome epithelium overlying PP facilitate the cytosolic passage of antigenic 
material from the intestinal lumen into the PP allowing the sampling of intestinal contents 
(Owen 1994). An immune response generated in the PP results in the emigration of primed 
lymphocytes into the lymph and circulatory systems (Croitoru and Bienenstock 1994; 
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Kiyono, et al. 1992; Phillips-Quagliata and Lamm 1994). Ultimately, the mucosally-primed 
immune effector cells home to the mucosal epithelium of the GI tract and may also 
potentially seed the lung and other distal mucosal sites (Kiyono, et aI. 1992; Wallace, et ai. 
1991). 
Organized mucosally-associated lymphoid tissue found in the lung is referred to as 
BALT (bronchus associated lymphoid tissue) and is most commonly associated with 
branch-points of conducting airways (Bienenstock and Befus 1984). Although organized 
lymphoid tissue is not a constitutive feature in human or murine lungs the lymphoid 
accumulations along the walls of bronchioles that are characteristic of FB may possess 
specialized epithelial cells analagous to M cells in the gut (Bienenstock and Befus 1984; 
Pabst 199; Neutra 1996). Lymphatics leading from BALT eventually drain into the lung 
associated lymph nodes (LN) where a local immune response may be generated (Morin, et 
al. 1994). 
While a number of studies have examined the nature of the immune response to 
particular mucosal pathogens, many of these organisms are able to colonize and stimulate 
specific immunity at only one mucosal site. Thus, it has been difficult to study cross 
priming between mucosal sites using the same pathogen. Reovirus serotype l/strain Lang 
(reovirus IlL) has been used extensively in our laboratory to study both the cellular and 
humoral components of the gut mucosal immune system (London, et al. 1987, 1989, 1990). 
In the gut, reovirus IlL induced in PP a B cell response chiefly comprised of reovirus llL-
specific IgA + memory cells (London, et al. 1987) as well as a switch in the 
immunoglobulin isotype potential of previously primed, but antigenically unrelated B cells 
to IgA (Cebra , et ai. 1989). In addition, MHC restricted, CD8+ virus specific precursor 
and effector cytotoxic T lymphocytes (CTL) were present in PP and the epithelium of the 
gut mucosa after enteric reovirus IlL infection (London, et al. 1987, 1989). Therefore, 
reovirus IlL is an effective gut-mucosal immunogen eliciting a humoral as well as a cellular 
immune response. Since reoviruses are isolates of both the lung as well as the gut (Sabin 
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1959), we chose to investigate whether reovirus could serve as an effective respiratory 
pathogen which stimulates the appearance of a lymphocytic infiltrate in the lung. In this 
report we describe a reovirus IlL-induced murine model of respiratory mucosal immunity 
which will allow investigations of the mucosal immune response generated at respiratory 
surfaces as well as the interaction between the lung and other mucosal immune sites. In 
addition, the follicular organization of the lymphoid infiltrate in the lungs of CD-l mice 




Clinical and pathological observations of reovirus IlL-infected CD-I mice 
To assess the affect of respiratory reovirus infection in an experimental animal 
model system, CD-I, C3H, and Balb/C mice were observed over time after intranasal (Ln.) 
inoculation with 1 X 107 plaque forming units (PFU) of reovirus IlL. This inoculation 
dose was selected since we had previously demonstrated this dose to be an effective 
stimulus for reovius-specific immune responses in the GJ tract of mice (London, et ale 87). 
The viral inoculum was administered in a volume of 30 , . .tI. We determined this was a 
sufficient volume to ensure the widespread distribution of the inoculate by Ln. administering 
30 J.d of a I: 1000 dilution of india ink to CD-I mice. We then immediately sacrificed the 
animal and removed the lungs for gross observation, which demonstrated that the india ink 
had been distributed to all regions of the lung (Figure 3.1). Following reovirus I/L-
inoculation experimental. and control animals were visually monitored for clinical 
manifestations of disease over time. No mortality of reovirus IlL-inoculated mice was 
observed over an 80 day period of observation. However, reovirus IlL infected mice 
showed obvious clinical signs of infection. By day 7, experimental animals were 
significantly less physically active compared to control saline inoculated mice and these 
mice developed a matted, unhealthy coat. These clinical changes were accompanied by a 
decrease in body weight which peaked 7 days after inoculation with an average 10% loss of 
total body weight versus controls (Figure 3.2A). The mice appeared to resolve the infection 
since they regained normal physical activity levels, their coats returned to a nonnal 
appearance, and their body weights returned to normal by the end of the third week (Figure 
3.2A). 
Gross observation of reovirus IlL-infected CD-I mouse lungs revealed a marked 
alteration in their appearance during the first two weeks of the infection. As compared to 
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Figure 3.1: An India ink colored test inoculum is widely distributed in the lung. A 30 J.lI 
volume of India ink, diluted 1: 1000 in water was administered either i. t. or i.n. to CD-1 
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Figure 3.2. Body and lung weights of reovirus IlL-infected mice. (A) The body weights 
of reovirus IlL-inoculated ( • ) and saline inoculated ( ---0-- ) CD-I mice are 
represented as the average percentage of the initial body weight at each timepoint. The 
initial body weight of an animal was determined by averaging the weight of the animal 
during the first three days of the experiment. Data represents the average of at least 6 
reovirus inoculated mice and 3 control mice per timepoint with the exception of the control 
mice on day 22 where N = 2. (B) The lung weights of two reovirus inoculated mice are 
represented at each timepoint. 
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control, saline inoculated lungs, reovirus IlL-infected lungs were edematous with pale 
subpleural zones alternating with areas of hemorrhage (Figure 3.3). Hyperplasia of the 
lung-associated LN occurred during the first week of the infection. An example of 
hyperplastic lung-associated LN 9 days following reovirus infection is shown in Figure 3.3. 
In contrast, the lung-associated LN are not observable in control animals (Figure 3.3). This 
hyperplasia persisted until at least day 21 (data not shown), Lung weights were detennined 
to quantitate the gross pathological changes observed in reovirus IlL-infected mice. These 
measurements demonstrated an increase in lung weights which peaked on day 11 with an 
approximate 2.5 fold increase in weight as compared to control lungs (Figure 3.2B). 
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Figure 3.3: Gross pathology of reovirus IlL-infected lungs. (A) Saline inoculated control 
lung. (B) Reovirus IlL-infected lungs 9 days after inoculation. Hyperplastic lung-
associated lymph nodes, unobservable in saline inoculated control lungs (A) are shown in 
reovirus infected lungs (B, arrow). 
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Figure 3.4. Detection of reovirus replication in the lungs of CD-I mice. Northern analysis 
was performed using a [32PJ-Iabeled probe derived from the full length reovirus M3 gene 
on total cellular RNA from lungs of reovirus IlL-infected or saline inoculated control mice. 
Lane 1, uninfected control; Lane 2, day 1 post inoculation; Lane 3, day 2 post inoculation; 
Lane 4, day 3 post inoculation; Lane 5, day 4 post inoculation; Lane 6, day 5 post 







Figure 3.5. Detection of reovirus replication in the lung of C3H mice. Northern analysis 
was performed using a [32PJ-Iabeled probe derived from the full length reovirus M3 gene 
on total cellular RNA from lungs of reovirus IlL-infected or saline inoculated control 
mice. Lane 1, uninfected control; Lane 2, day 1 post inoculation; Lane 3, day 2 post 
inoculation; Lane 4, day 3 post inoculation; Lane 5, day 4 post inoculation; Lane 6, day 5 
post inoculation; Lane 7, day 6 post inoculation; Lane 8, day 7 post inoculation; Lane 9, 
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Figure 3.6. Infectious virus titers of the lungs of reovirus llI...-infected CD-l mice. The 
average +/- S.E. number of plaque forming units (PFU) per whole lung was determined 
from the lungs of three mice per timepoint. *No plaques were detected at the limit of 
detection (50 PFU/lung) from the lungs of saline inoculated controls or from the lungs of 
reovirus llI...-inoculated mice 14 days after infection. 
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Histopathological alterations in reovirus IlL-infected CD-I mouse lungs 
Histological observations of reovirus IlL-infected or control CD-I lungs were made 
on H&E stained paraffin embedded lung sections. By day 6 numerous foci of edema 
accompanied by mononuclear cell infiltration (Figure 3. 7B) were observed as compared to 
control saline inoculated lungs (Figure 3.7 A). Few neutrophils, eosinophils, or mast cells 
were observed. The cellular infiltrate was primarily located in the peri-bronchiolar alveolar 
spaces and became more tightly condensed by day 11 (Figure 3.7C). At three weeks much 
of the edema and original cellular infiltrate had disappeared (Figure 3.7D). However, 
peribroncholar lymphoid follicles indicative of the condition "follicular bronchiolitis" had 
formed (Figure 3.7D, arrows). Normal bronchioles, alveolar ducts, and alveoli can be 
observed in control saline inoculated lung tissue (Figure 3.7 A). 
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Figure 3.7. Histological characterization of the lung of reovirus IlL-infected CD-l mice. 
H&E staining was performed on formalin-fixed, paraffin-embedded lung sections. (A) 
Saline-inoculated controls; (B) 6 days post reovirus inoculation; (C) 11 days post reovirus 
inoculation; and (D) 21 days post reovirus inoculation. All photographs were taken at 
100X magnification. 
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Observation at a higher magnification was used to reveal the mononuclear 
characteristics of the interstitial and intra-alveolar infiltrate in the lungs of CD-l mice. Two 
distinct yet overlapping processes were observed following reovirus IlL infection. The first 
and predominant process involved the generation of cellular damage in the interstitial and 
alveolar spaces during the inflammatory response initiated by reovirus infection. At day 6 
proteinaceous residue of pulmonary edema was present in the airspaces (Figure 3.8A). In 
addition, nuclear fragmentation was observed in active inflammatory lesions (Figure 3.8A, 
arrow). A Gordon and Sweet reticulin stain (GSR) demonstrated most of the alveolar 
supporting reticulin was intact with only occasional evidence of fragmentation of the 
reticulin framework (Figure 3.9B, arrow). It was also evident by GSR staining that the 
alveoli were filled with and expanded by a cellular infiltrate (Figure 3.9B). In addition to the 
largely lymphocytic population that had been observed throughout the infection, at day 11 
large numbers of macrophages were also found in the airspaces and interstitium (Figure 
3.9C, small arrows). Surfactant secreting alveolar type II cells were also observed to be 
enlarged at day 11 (Figure 3.9C, large arrows). At three weeks, prominent peri-bronchiolar 
interstitial lymphoid follicles were present (Figure 3.9D) and foamy macrophages could be 
observed in the air spaces (Figure 3.9D, arrows). 
The second process was evident later in the infection and is characterized by an 
association of plasma cells with the vasculature of the lung. At day 11 lymphocytes were 
present adjacent to the pulmonary arteries in the lymphatic and connective tissue spaces 
(Figure 3.9A, arrows). By day 21, the lymphatic and connective tissue space adjacent to the 
pulmonary arteries contained cells predominantly of a plasmacytic nature 
(Figure 3.9B, arrows). 
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Figure 3.8. Histological characterization of the reovirus IlL-induced inflamatory infiltrate 
in CD-l mice. (A) H&E staining at 11 days post reovirus inoculation showing lymphoid 
populations in the connective and lymphatic tissue (arrows) adjacent to a pulmonary artery 
(PA); (B) H&E staining at 28 days post reovirus inoculation showing plasma cells (arrows) 
adjacent to a pulmonary artery (P A). Both photographs were taken at 400X magnification. 
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Figure 3.9. Histological characteristics of the lymphoid plasmocytic reaction to reovirus-
IlL infection in CD-l mouse lungs lung. (A) H&E staining showing nuclear fragmentation 
(arrow) at 6 days post reovirus inoculation; (B) GSR staining showing minor reticulin 
damage (arrow) at 5 days post reovirus inoculation; (C) H&E staining showing increased 
number of macrophages in the airspaces (small arrow) and swollen alveolar type II cells 
(large arrows) at 11 days post reovirus inoculation; (D) H&E staining showing foamy 
macrophages (arrows) at 28 days post reovirus inoculation. All photographs were taken at 
400X 
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Immunohistochemical localization of lymphocyte populations in reovirus IIL-
infected lungs 
Immunohistochemistry was used to examine the phenotype of the cells infiltrating 
the lungs after reovirus IlL infection. Saline inoculated mice were used as controls. At day 
6 of the infection CD4+ (Figure 3.10B) and CD8+ (Figure 3.IOD) lymphocytes were 
diffusely scattered throughout the lesion and had infiltrated into the interstitial and alveolar 
spaces. CD4+ (Figure 3.IOA) and CD8+ (Figure 3.10C) lymphocytes were not observed 
in saline inoculated control lungs. In addition to a T cell response, a B cell infiltrate was 
observed in reovirus IlL-infected lungs (Figure 3.IOF). Although B220+ lymphocytes 
could be found scattered throughout all compartments of the lung, the majority of B220+ 
lymphocytes surrounded the pulmonary arteries accompanying the conducting airways 
(Figure 3.IOF). B220+ lymphocytes were not observed in saline inoculated lungs (Figure 
3.10E). In comparison to the resident alveolar macrophage population found in the air 
spaces of control lungs (Figure 3.10G), a large increase in the number of Mac 1 + cells was 
observed in reovirus IlL-infected lungs (Figure 3.IOH). These Mac-l + cells were more 
numerous, phenotypically larger and more irregularly shaped (Figure 3. IOH) than the 
Mac-1 + cells of the control lung (Figure 3.100). 
Figure 3.10: Immunohistochemical analysis of the reovirus induced cellular 
infiltrate in CD-I mice. Frozen sections prepared from coptrollungs 6 days 
post saline inoculation were stained with: (A) anti-CD4 ; (C) anti-CD8 ; (E) 
anti-B220 ; and (G) anti-Mae-I. Identically treated lungs 6 days post 
reovirus IlL-infection were stained with: (B) anti-CD4 ; (D) anti-CD8 ; (F) 
anti-B220 ; and (H) anti-Mae-I. The sections were counterstained with 
Hematoxlyn after the immunostaining procedure. All photographs were 




Reovirus infection of the GI tract has provided a useful model for addressing 
fundamental questions of gut mucosal immunity (London, et al. 1987, 1989, 1990). 
Although the immune response at the mucosal surfaces of the lung has been studied 
extensively by utilizing various microbial models of infection (Allan, et al. 1990; Graham, et 
al. 1991, Hou, et al. 1992, Murphy 1994), the majority of these models have been limited by 
the microorganism's restricted immunogenicity to a single mucosal site. Therefore, it has 
been difficult to study the interaction of the respiratory and gut-mucosal immune systems in 
response to a single pathogen. In this report we demonstrate that respiratory reovirus 
infection elicits an acute lymphocytic inflammatory infiltration of the lung and hyperplasia 
of the lung-associated LN. Thus, respiratory reovirus infection provides a useful model for 
the study of respiratory-mucosal immunity and the relationship of respiratory and gut-
mucosal immunity to the H common mucosal immune system". 
Since the characterization of the Reoviridae family of viruses as respiratory and 
enteric isolates (Sabin 1959), a number of reovirus strains were found to induce pathology 
of a number of organs systems including the eNS, heart, pancreas, and thyroid (Sharpe and 
Fields 1985; Onodera and Awaya 1990; Sherry 1993; Yukawa 1993). During the 1960s 
and early 1970s the effect of reovirus infection of the respiratory tract was studied by 
several investigators. These early studies demonstrated that the i.n. application of 
mammalian or avian reovirus strains to newborn or weanling mice resulted in the 
establishment of a respiratory infection (Hobbs 1965, Klein, et al. 1967 Stanley 1974). 
Delayed bacterial clearance from reovirus-infected lungs was also demonstrated in these 
studies (Klein, et al. 1967, 1969). Recently, it has been reported that reovirus enters the 
BAL T of rats via M cells in a manner analogous to the entry of reovirus into the PP of the 
gut (Morin, et al. 1994). While the histopathology of reovirus infection was not addressed 
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in this study, reovirus virions were observed associated with type 1 alveolar epithelial cells 
suggesting that infection of the lung epithelium and viral replication may occur at this site. 
We have found that Ln. inoculation of CD-l mice with reovirus IlL results in a 
severe acute viral bronchopneumonia that is histologically similar to the murine model of 
respiratory syncytial virus infection (Connors, et ale 1992, Murphy 1994). The most 
obvious characteristic of the reovirus IlL induced respiratory disease is an intense 
mononuclear inflammatory infiltrate related to small bronchioles and pulmonary arteries. 
This disease pattern can be divided into two overlapping processes. The first and 
predominant process is characterized by an inflammatory response in the airspaces and 
interstitium of the lung. The peri-bronchiolar location of the inflammatory infiltrate, which 
can be visualized as early as day 3 of the infection, coupled with the observation of nuclear 
fragmentation at this site several days later suggests that viral infection and replication 
occurs in this region of the lung. As the infection progresses, the initially diffuse cellular 
infiltrate becomes more focused around small bronchioles. Although the airspaces become 
packed with lymphocytes, the reticulin framework of the lung remains largely intact. While 
viral replication diminishes during the later part of the first week of the infection, and 
infectious virions are eliminated during the second week, the acute phase of the 
inflammatory response persists and continues to organize during this time. Within the 
lesion a second process occurs resulting in the accumulation of plasma cells in the 
lymphatic and connective tissue adjacent to pulmonary arteries. As this second cellular 
event progresses, the original infiltrate concurrently becomes more condensed and 
organized, primarily around bronchioles, and includes an increasing number of 
macrophages. By the third week, foamy macrophages, indicative of macrophage mediated 
clearance of cellular debris and edema, are present in airspaces and terminal bronchioles. 
We also demonstrate the probability that the potent lung inflammatory response 
induced by reovirus IlL is not simply a nonspecific reaction to viral infection or damage to 
the alveolar epithelium. First, the absence of a potent inflammatory lung response by CD-1 
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mice after i.n. inoculation with reovirus 310 demonstrates that the respiratory reovirus 
model of lung inflammation is reovirus serotype specific. In addition, by moving the model 
of respiratory reovirus IlL infection to outbred mouse strains Balb/C and C3H we show 
that the genetic background of the host animal may influence the intensity of the 
inflammatory response to reovirus IlL. Intranasal inoculation of Balb/C mice with reovirus 
IlL induces a pattern of pulmonary inflammation that closely parallels the peri-bronchiolar 
accumulation of mononuclear cells observed in CD-I mice after Ln. inoculation with 
reovirus IlL. However, the pulmonary response of C3H mice to Ln. inoculation with 
reovirus IlL is considerably less severe and does not result in the prominent FB-like 
organization of infiltrating mononuclear cells. Although the variability observed in the 
reovirus IlL-induced pUlmonary responses among CD-I, Balb/C, and C3H mice may seem 
to indicate that infectious reovirus IlL would be cleared from the lung with kinetics that 
would be directly related to the intensity of the inflammatory response, assessment of viral 
replication by northern analysis indicates that the reovirus replication kinetics are similar 
between the strains. 
In situ immunohistochemical analysis of reovirus-infected CD-I lungs was 
performed to characterize the composition of the cellular infiltrate of the lung. This analysis 
revealed the presence of CD4 + and CD8+ T -lymphocytes, B-Iymphocytes, and 
macrophages in the airspaces and interstitial tissues of reovirus IlL-infected lungs. Thus, 
any of these cellular populations may be involved in either the clearance of the viral infection 
and/or be associated with the persistence of the inflammatory infiltrate. Clearance of 
infectious viruses from the lung is frequently associated with a CTL response mectiated by 
MHC class I restricted CD8+ T lymphocytes (Allan, et ai. 1990; Hou, et al. 1992; Taylor, 
et al. 1985). It is possible that the CD8+ lymphocytes infiltrating reovirus-infected lungs 
are performing an analogous function. Our observation that infectious reovirus virions are 
cleared with similar kinetics to that observed in experimental influenza and Sendai virus 
infections (Eichelberger, et al. 1991; Hou and Doherty 1995) may support this hypothesis. 
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In addition, we have demonstrated lysis of reovirus-infected target cells by both pulmonary 
and lung-associated LN lymphocytes obtained from reovirus-infected but not normal Balb/c 
mice (Thompson, et al. 1996). The function of CD4 + helper T cells in the mediation of 
viral clearance from the lung is unclear, making their role in lung immunity difficult to 
assess (Allan, et al. 1990; Connors, et al. 1992). In vivo depletion of CD4 + cells in the 
influenza model only delays the clearance of influenza virus by four days (Allan, et al. 
1990), although the CD4 + population also appears to be a primary source of TH2 
associated cytokines (Sarawar and Doherty 1994). Conversely, in vivo depletion of CD4 + 
but not CD8+ cells abrogates the histopathology observed in respiratory syncytial virus 
infected mice (Connors, et al. 1992). The role of the CD4+ T lymphocytes in reovirus 
infected lungs remains to be determined. 
Although the humoral component of the respiratory reovirus III response in this 
model has not been investigated, the presence of B220+ cells adjacent to pulmonary arteries 
during the first week of infection and the appearance of plasma cells at the third week in the 
same location suggests that a reovirus-specific component of the pulmonary B cell response 
is occurring. If reovirus-specific B cells exist in the lung, they may either be locally 
generated or be the progeny of viral-specific B lymphocytes which have emigrated from the 
lung-associated LN. Most investigations of the humoral immune response in the lung 
indicate that IgO is the predominate isotype in lower respiratory tract secretions (Reynolds, 
1991). One group, however, reports that IgA predominates over other isotypes in an 
experimental influenza model (Fazekas, et al. 1994). It will be of interest to determine the 
isotype profile of reovirus-specific antibodies in the lung and to correlate the isotype profile 
of reovirus-specific antibodies of the lung and gut after various mucosal routes of 
immunization. 
Respiratory reovirus infection generates a potent mucosal inflammatory response 
that makes reovirus a suitable probe for respiratory mucosal investigations. The results 
reported in this chapter suggest that reovirus can be used to develop a practical model of 
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respiratory mucosal immunity that will contribute to an understanding of the pulmonary 
immune response and more broadly, its relationship to the common mucosal immune 
system. Most importantly this model will provide an opportunity to compare immune 
responses to the same immunogen at remote mucosal surfaces, namely between the lung 
and GI tract. In addition to these applications, respiratory reovirus infection provides a 
potentially useful model for the study of a spectrum of inflammatory lung diseases. The 
follicular organization of the lymphoid infiltrate in the lungs of CD-l mice following 
reovirus infection is similar to the human condition termed follicular bronchiolitis (FB). FB 
is characterized by enlarged peri-bronchiolar lymphoid follicles that restrict airflow by the 
compression of the bronchioles (Wells and du Bois 1993). In humans FB may be 
associated with environmental factors such as viral infections or the inhalation of tobacco 
smoke (Wells and du Bois 1993). Additionally, FB may be a component of systemic 
disorders with a predilection for connective tissue diseases which are characterized by 
increased fibroblast activity and matrix deposition (Myers and Colby 93, Wells and du Bois 
93). Additionally, as addressed in the subsequent chapter, I observed that CBAI] mice in 
response to respiratory reovirus IlL infection develop the intraluminal fibrotic syndrome 
Bronchiolitis Obliterans Organizing Pneumonia (BOOP), or the acute inflammatory 
disorder, Acute Respiratory Distress Syndrome (ARDS) (Bellum, et al. 1997). BOOP, and 
ARDS, like FB, are considered to belong to a spectrum of lymphocytic inflammatory 
diseases of the small aitways of the lung (Myers and Colby 1993; Wright, et al. 1992). 
However, BOOP is characterized by the formation of intraluminal fibroblastic plugs in 
terminating bronchioles, alveolar ducts, and airspaces in addition to the usual presence of an 
organizing lymphocytic (Myers and Colby 1993). The development of ARDS also has 
underlying similarities to the generation of FB and BOOP, but is primarily characterized by 
extensive vascular damage that results in the flooding of the air spaces with edema (Myers 
and Colby 1993; Wright, et al. 1992). While BOOP, ARDS and FB are different 
syndromes which to date have not been linked in a causal relationship, our results suggest 
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that comparative differences in the respiratory response to reovirus among strains of mice 




Respiratory Reovirus IlL-Induced Bronchiolitis Obliterans 
Organizing Pneumonia: A Model for the Study of 
Bronchoalveolar Intraluminal Fibrosis 
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Introduction 
Acute, inflammatory responses that occur in the distal air spaces of the lung 
(bronchioles, alveolar ducts, and alveoli) may develop into one of a limited number of 
nonspecific pulmonary disorders characterized by fibrosis (Cordier, et al. 1994; Myers, et 
al. 1994; Katzenstein and Askin 1990; Kuhn, et ale 1989). The pathologic features of a 
fibrotic response in the lung may include interstitial collagen deposition as observed with 
usual interstitial pneumonia (VIP), interstitial fibroblast proliferation as observed with 
diffuse alveolar damage (DAD), or intraluminal fibroblast proliferation as observed for a 
relatively recently described disorder termed bronchiolitis obliterans organizing pneumonia 
(BOOP) (Myers, et ai. 1994; Epler, et al. 1985), BOOP lesions have a patchy distribution 
in the lung, are frequently associated with a peri-bronchiolar organizing pneumonia and also 
with the presence of lipid - laden foam cells in the alveolar spaces (Colby 1992). The 
structural integrity of alveolar ducts and walls within regions of BOOP lesion development 
are normally preserved; however, the alveolar septa may be thickened with an infiltrate of 
inflammatory mononuclear cells (Colby 1992). Since the initial description of BOOP by 
Epler and co-workers in 1985, an increasing number of reports of BOOP have appeared in 
the literature and BOOP is now accepted as a distinct clinical syndrome. While it has been 
documented that BOOP lesion development can be a secondary disorder to a number of 
pulmonary infections (which are frequently believed to be viral), most BOOP cases are not 
associated with any identifiable pathogen and are classified as idiopathic BOOP (Kuwano, 
et al. 1990; Epler 1992). Furthermore, a smaller group of BOOP cases have been 
associated with toxic fume exposure, connective tissue disorders, and as a clinical 
complication associated with a subset of lung and bone marrow transplantation (Myers, et 
al. 1994; Martinez and Lynch 1994; Mathew, et ale 1994; Thirman, et al. 1992). BOOP is 
normally treated with corticosteroids; however, some patients experience a spontaneous 
remission of BOOP and approximately one third of patients that have been administered 
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corticosteroids still show evidence of BOOP lesions at the end of treatment (Izumi 1994). 
Additional recent literature also suggests that not all BOOP cases respond well to steroids 
and that BOOP can be fatal in a small subset of cases (Nizami, et ai. 1995; Epler 1995) 
Although BOOP is a well established syndrome, a small animal model developed for 
investigations of BOOP lesion development has not been described in the literature. 
Therefore, little is known concerning the cellular and molecular mechanisms that mediate the 
formation and resolution of BOOP lesions. Although existing models of experimental 
pulmonary fibrosis have been useful for histopathological and functional investigations of 
other types of fibrotic events in the lung, they fail to accurately reflect the intraluminal and 
fibroblastic nature of the bronchoalveolar obliteration observed in BOOP lesions (Piguet, et 
al. 1990; Zhang, et al. 1996). Therefore, while these models are of interest for the study of 
interstitial lung fibrosis or collagen scarring they are not directly relevant for the study of 
BOOP. This chapter describes the first virus-induced model of BOOP in which CBAlJ 
mice are intranasally (Ln.) inoculated with reovirus IlL and subsequently develop BOOP 
lesions, which morphologically resemble BOOP in humans. These BOOP lesions, like 
those observed in humans, are characterized by the patchy distribution of intraluminal plugs 
of granulation tissue that appear to be chiefly composed of fibroblast like cells and by 
limited collagen deposition. The development of BOOP lesions 'in this animal model is 
preceded by a similarly patchy distribution of peri-bronchiolar mononuclear cell 
inflammatory lesions which progress into characteristic well developed BOOP lesions 
during the second and third week post infection. 
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Results 
Respiratory reovirus tIL infection of CBAlJ mice· induces intraluminal fibrotic 
lesions 
We have previously described the pulmonary inflammatory response of CD-l and 
Balb/c mice after the intranasal inoculation of 1 x 107 PFU of reovirus IlL (Bellum, et al. 
1996, Thompson, et al. 1996). Both strains responded with a well delineated, peri-
bronchiolar lymphocytic inflammatory response with 100% of the experimental animals 
surviving the infection. In contrast, the intranasal inoculation of CBAlJ mice with 1 x 107 
PFU of reovirus reovirus IlL resulted in a severe clinical illness characterized by extensive 
damage to the lung vasculature and resulted in a mortality rate approaching 90% in the 
second week after reovirus IlL inoculation (Table I, chapter 5). This acute pattern of 
inflammation recapitulated the human small airway disease termed acute respiratory distress 
syndrome (ARDS). When the lungs of surviving mice were examined histologically, we 
observed the presence of lesions which were similar to those observed in humans and 
characterized as bronchiolitis obliterans organizing pneumonia (BOOP). In Figure 4.1, a 
well formed BOOP lesion 21 days after reovirus IlL infection of CBAlJ mice is shown. In 
this figure a characteristic fibrous cellular plug is present in an alveolar duct, which indicates 
the lesion has a proximal acinar location in the lung. As shown in this figure, these well-
formed lesions are frequently present in areas of the lung which are otherwise histologically 
unaffected and normal. 
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Figure 4.1. Histologic characterization of a well fonned BOOP lesion. H & E staining of 
a characteristic fibrous cellular plug found in an alveolar duct at 21 days post i.n. 
inoculation with 1 x 107 PFU of reovirus IlL. Objective magnification, X 20. 
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Histopathological Analysis of the Temporal Development of BOOP Lesions in 
CBAlJMice 
While we have demonstrated the presence of BOOP lesions in CBNJ mice 21 days 
after respiratory reovirus IlL infection, a particular advantage of this model system is the 
ability to study the development of such lesions over time after the initiation of a known 
viral infection. These studies clearly demonstrate that the formation of BOOP lesions are 
preceded by a patchy inflammatory mononuclear cell infiltrate that progressively becomes 
more organized during the first three weeks of the infection. A kinetic analysis of the 
formation of BOOP lesions in CBNJ mice is shown in Figure 4.2. In Figure 4.2A, the 
response to reovirus IlL at day 7 is typically characterized by an inflammatory cellular 
infiltrate that demonstrates a typical focus of an active viral pneumonia. At day 7, the 
cellular infiltrate is characterized by mononuclear cells and macrophages that are in the air 
spaces and the interstitium (Figure 4.2A). An analysis of lung sections at low power 
demonstrates that these diffuse inflammatory infiltrates have a patchy distribution 
throughout the lung and that these are often in a proximal acinar location (data not shown). 
At day 14, an increase in the number of macrophages and the formation of condensed focal 
lymphocytic accumulations are observed (Figure 4.2C, arrow). At day 21 the 
peribronchiolar mononuclear infiltrate is characterized by a more prominent lymphocytic 
proliferation (Figure 4.2E, arrows). The infiltrate at day 21 is still present in the 
interstitium and airspaces, including the presence of intra-alveolar macrophages. 
In addition to the mononuclear cell inflammatory response, the development of fibrotic 
lesions can also be observed to occur during the three week time course of the infection. At 
day 7, the proximal acinar development of young fibrous polyps of collagenous tissue (FP) 
can be observed (Figure 4.2B). While these types of lesions are not commonly found at 
day 7, when present, they demonstrate that proliferative fibroblastic lesions can develop in 
association with an area containing an inflammatory infiltrate both within the alveolar spaces 
and within the interstitium (Figure 4.2B). At day 14, young fibroblastic polyps continue to 
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organize in the air spaces and foamy macrophages (arrow) ~ observed in the air spaces 
surrounding the lesion (Figure 4.2D). The relationship of this lesion to a small pulmonary 
artery (PA) indicates that the location of the lesion in the lung is proximal acinar (Figure 
4.2D). The fibroblastic polyps appear to develop simultaneously in tenninal bronchioles, 
alveolar ducts, and alveolar spaces. In contrast to humans, respiratory bronchioles (RB) are 
typically absent in mice, and when present, are poorly developed and defined by the 
presence of only a few ciliated bronchiolar epithelial cells. {phalen 1984) The location of 
fibroblastic polyps observed in this model include regions of the acinus analogous to RB in 
humans. The further development of these lesions can be observed at day 21 where a well -
fonned fibroblastic polyp is observed in an alveolar duct (Figure 4.1 and 4.2F). 
In contrast to the above described pattern of the development of mononuclear cell 
inflammatory infiltrates and BOOP lesions, control mice inoculated with saline do not 
develop an observable inflammatory (Figure 4.2G). Infectious reovirus virions are required 
to initiate the inflammatory response and the development of fibroblastic lesions. This is 
demonstrated by the inoculation of CBAlJ mice with a non-replicating preparation of 
reovirus 11L (produced by exposure of infectious virions to a UV light source) which 
contains less than 5 PFU/ml of infectious virions as detennined by titration on L-929 
fibroblast mono layers (data not shown), CBAlJ mice inoculated with non-replicating 
virions do not develop an observable inflammatory response (Fig. 4.2H). 
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Figure 4.2. Temporal analysis of the pulmonary inflammatory response and fibrotic 
reaction as shown by H & E staining after i.n. inoculation with 1 x 107 PFU of reovirus IlL. 
The inflammatory mononuclear cell infiltrate, which is initially diffuse at day 7 post 
inoculation (A), is characterized by condensed lymphocytic accumulations (arrow) at day 14 
(C), and by more prominent peribronchiolar lymphocytic proliferation (arrows) at day 21 
(E). The stages of development of fibroblastic lesions include the association of young 
fibrous polyps (FP) at day 7 (B), the continued organization of FP in air spaces and 
observation of foamy macrophages (arrow) at day 14 post inoculation (D). The proximal 
acinar location of the lesion is indicated by the relationship of the lesion with a pulmonary 
artery (PA). At day 21 post inoculation well formed fibroblastic polyps are observed in 
alveolar ducts (F). Saline inoculated (G) and UV inactivated reovirus IlL (H) controls are 
shown 7 days post inoculation. Objective magnification, X 10.(A, C, and E) and X 20 (B, 
D, F, G, and H). 
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To further characterize the nature of the cellular response in this model, Verhoeff Van 
Gieson (VVG) - stained, paraffin embedded lung sections were analyzed since this elastic 
tissue stain allows a better appreciation of the architecture of the lung. At 7 days, the 
cellular infiltrate, which is chiefly composed of lymphocytes and macrophages, is present in 
the interstitium, alveolar spaces, and alveolar ducts (Figure 4.3A). In Figure 4.3A, a cuff of 
mononuclear cells is observed around a pulmonary artery (PA). At day 14, fibrous tissue 
(F) is observed in the alveolar ducts and alveoli (Figures. 4.3B and 4.3C). When these 
images are viewed in color, pink staining collagen can be discerned morphologically in the 
fibrous tissue shown in Figure 4.3C. Elsewhere at this time the cellular accumulation has 
become more histiocytic and more fibrous (Figures. 4.3B and 4.3C). By day 21, 
prominent clustering of foamy macrophages in the air spaces associated with BOOP lesions 
is observed (Figure 4.3D). 
A Gordon and Sweets stain for reticulin (GSR) was performed on paraffin - embedded 
reovirus IlL infected lung sections to detect changes in the supporting architecture of the 
lung during the development of BOOP lesions (Figure 4.4). At day 14, reticulin-containing 
organizing fibrous tissue in alveolar ducts is observed (Figure 4.4A, arrow). In addition, 
reticulin fibers are observed in close association with clusters of macrophages within the 
airspaces of BOOP lesions (Figure 4.4B, arrow). 
Hyperplasia of the lung associated lymphoid tissue is also a feature of the inflammatory 
response to respiratory reovirus IlL infection. The lung associated lymphoid tissue at 7 
days post reovirus IlL inoculation is present in small amounts about a core of adipose 
tissue in the hilum of the lung (Figure 4.5A). By day 14, the lung associated hilar lymphoid 
tissue shown in figure 4.5B at the identical magnification as figure 4.5A, had undergone 
dramatic lymphoid hyperplasia increased in size and is densely packed with lymphocytes 
(Figure 4.5B). Germinal centers (GC) are also present in the lung associated lymphoid 
tissue at day 14 (Figure 4.5B). 
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Figure 4.3 Further histologic characterization of the cellular response in CBA/J mice 
induced by 1 x 107 PFU of reovirus-IlL. VVG staining shows a cuff of mononuclear cells 
around a pulmonary artery (PA) adjacent to a bronchiole (Br) at day 7 post inoculation (A). 
Fibrous tissue (F) at day 14 (B) and fibrous tissue with collagen also observed at day 14 
(C) are found in alveolar ducts and alveoli. Clustering of foamy macrophages in air spaces 
associated with BOOP lesions at day 21 (D). 
Objective magnification, X 40. 
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Figure 4.4. Histologic characterization of alterations in lung architecture in CBAlJ mice 
after inoculation with 1 x 107 PFU of reovirus IlL. GSR staining at day 14 post 
inoculation shows reticulin containing fibrous tissue (arrow) in alveolar ducts (A) and a 
close association of reticulin fibers (arrow) with macrophages (B). 
Objective magnification, X 10 (A) and X 64 (B). 
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Figure 4.5. Histologic characterization of lung associated lymphoid tissue hyperplasia frpm 
a CBAlJ mouse after inoculation with 1 x 107 PFU of reovirus IlL. H & E staining of hilar 
lymphoid tissue at day 7 post inoculation (A) and at day 14 with a genninal center (GC) 
shown (B). 
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Ultrastructural Characterization of BOOP Lesions 
Transmission electron microscopy (TEM) was used to examine BOOP lesions in 
the lungs of CBAlJ mice 19 days post reovirus inoculation (Figure 4.6). The electron 
microscopic view of the BOOP lesion in Figure 4.6A depicts the extension of a collagenous 
lesion (Col) into the air space, which is defined by an epithelial type I cell (E, center of field) 
and a type II cell (IT, left center). The cellular processes of fibroblasts (F) that have 
interdigitated into the collagen bundles can also be observed in the lesion (Figure 4.6A). A 
pulmonary epithelial cell (E) lines the alveolar extension of the fibrotic (BOOP) lesion and 
an alveolar macrophage (M) is also present (Figure 4.6A). Figure 4.7B shows another ultra 
structural feature of a BOOP lesion. In this electron micrograph, long strands of young 
fibroblast processes can be seen embedded in a matrix of glycosaminoglycans (GAG) 
(Figure 4.6B). Macrophages are also present in close association with fibroblasts and the 
extracellular material of this lesion (Figure 4.6B), 
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Figure 4.6. Ultrastructural characterization of a BOOP lesions. At 19 days after 
inoculation with 1 x 107 PFU of reovirus IlL transmission electron microscopy shows a 
lesion composed of collagen (Col) and fibroblasts (F) in close association with alveolar 
epithelial type I (E) and type II (II) cells, extending into an alveolar space (Alv), (A). A 
macrophage (M) and red blood cell (RBC) are also observed. Macrophages (M) and 
cellular processes of fibroblasts (F) are found embedded in a matrix of glycosaminoglycans 
~~hlhc~~lon, X 6250. 
Immunohistochemical Localization of Reovirus Associated Proteins in 
Reovirus tIL - infected Lungs 
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Immunohistochemistry was used for the in situ identification of reovirus-encoded 
proteins in this model. At day 1, a patchy distribution of reovirus-encoded proteins is 
observed as a diffuse focus of deposition at low magnification (Figure 4.7A). Higher 
magnification of the same lesion demonstrates positive staining for reovirus proteins in a 
large number of cells; however, the precise nature of the cells cannot be determined because 
of the intensity of the staining (Figure 4.7B). At day 7, the immunoperoxidase product is 
still present on cells that appeared to be macrophages and alveolar epithelial cells (Figure 
4.7C). Control lungs stained at 7 days after inoculation with UV - inactivated reovirus IlL 
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Figure 4.7. Immunohistochemical analysis of reovirus - encoded proteins in CBNJ mice 
after i.n. inoculation with 1 x 106 PFU of reovirus IlL. Anti-reovirus staining was 
performed on frozen sections prepared on day 1 post inoculation, which is shown at low 
magnification (A) and higher magnification (B). Staining was also performed at day 7 (C) 
and on control lungs at day 7 post inoculation with UV inactivated reovirus IlL (D). 
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Clearance of Reovirus tIL from the Lungs of Infected Mice 
The clearance of virus from the lungs of mice infected with reovirus IlL was 
assessed by a standard plaque assay of lungs homogenized by sonication (Figure 4.8). At 
day 1 of the infection the average titer of infectious virions is 6.5 x 106 PFU/lung 
representing an approximately 65% increase from the initial viral inoculum of 1 x 106 PFU 
The titer increases to 7.5 x 106 PFUIlung on day 3 and drops to 2.7 x 106 PFUllung on day 
5. However, at day 7 a 1.5 log decrease of infectious virions is observed (1.2 x 105 
PFU/lung) as compared to the titer of infectious virus present on day 5. By day 21, 
infectious virions are not detected within the limits of the assay. Infectious virions are not 
observed in homogenized, saline inoculated control lung tissues (data not shown). 
Additionally, in a separate experiment reovirus IlL dissemination to tissues other than the 
lung also assessed by a standard plaque assay of homogenized spleen and Peyer's Patches 
(PP) during a one week time course after i.n. inoculation with 1 x 107 PFU of reovirus IlL. 
At day 1 of the infection the average titer of infectious virions in the lung, spleen, and PP 
was 2.1 x 108 PFU, 1.7 x 102 PFU and 3.5 x 103 PFU respectively. In lungs the titer 
increases slightly to 2.3 x 108 PFU/lung on day 3 and drops to 6.8 X 106 PFU/lung on 
day 7. Spleen and PP demonstrate approximately a ten fold increase in infectious virus titer 
from day 1 to day 3 after inoculation (spleen, 4 x 103 PFU and PP, 1.5 x lQ4 PFU), but then 
on day 7 (spleen, 3.3 x 102 PFU and PP, 5 x 102 PFU) both of these tissues show a return 
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Figure 4.8. Infectious virus titers of the lungs of reovirus IlL-infected mice. The average 
+ SE number of PFU -per whole lung was detennined from the lungs of three mice per 
timepoint. *No plaques were detected at the limit of detection (50 PFUllung) from the 
lungs of saline-inoculated controls or from the lungs of reovirus IlL-inoculated mice 21 
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Figure 4.9. Infectious titers of the lungs (D), spleen (II), and Peyer's patches 
(D). The average number of plaque forming units (PFU) per whole lung was 




BOOP belongs to a group of lung disorders whose response to acute lung injury is 
primarily characterized by fibroblast proliferation within the lumina rather than the 
interstitial deposition of collagen observed in other fibrotic lung diseases (Myers, et al. 
1994, Katzenstein and Askin 1990). However, unlike related fibroblast proliferative 
disorders such as the interstitial pneumonias and bronchiolitis obliterans, a constrictive 
bronchiolar disease, BOOP is distinguished from these by the following features: (i) the 
formation of connective tissue polyps in the lumina of distal air spaces; (ii) fibrinous 
exudates; (iii) the collection of foamy macrophages in the alveoli; (iv) the infiltration of 
alveolar walls with lymphocytes; (v) plugs of myxoid connective tissue in airspace lumina; 
(vi) the maintenance of lung architecture (Epler 1992). The current understanding regarding 
the development of BOOP is based largely on histopathologic and radiological observations 
and on pre-existing knowledge of mechanisms of fibrosis. BOOP is usually detected in 
humans as it approaches end stage (Epler, et al. 1985). In this setting, the cellular and 
molecular factors that were involved in the fonnation of BOOP can no longer be identified. 
While there are existing models of BOOP in the literature, they are either not practical 
because the use of large animals is involved, or they fail to accurately parallel the 
histopathologic observations of BOOP in humans (Castleman 1985; Fukuda, et al. 1985; 
Rhodes, et al. 1989). Since many cases of idiopathic BOOP in humans are believed to be 
the sequelae of undocumented viral infections (Kuwano, et al. 1990; Epler 1992), the 
development of a small animal model of virus-induced BOOP would aid investigations 
concerning the temporal development and resolution of the intraluminal fibroblastic lesions. 
A temporal analysis of respiratory reovirus IlL infection in CBAlJ mice 
demonstrated that the formation of BOOP lesions is preceded first by a patchy distribution 
of reovirus protein expression which is followed by a similar patchy distribution of 
inflammatory mononuclear cell infiltrates. These patchy inflammatory infiltrates have a 
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proximal acinar location and are initially loosely organized into the typical foci of an active 
viral pneumonia. During the three weeks following reovirus IlL inoculation, the initial 
mononuclear cell infiltrate condenses into prominent peri-bronchiolar lymphoid 
accumulations. However, in CBAlJ mice, a second process occurs in which a subset of 
lesions become infiltrated with fibroblasts and progress over the three week period into 
discrete BOOP lesions. The pattern of mononuclear cell organization without the 
involvement of intraluminal fibrosis, which is observed in CD-1 and Balb/c mice, results in 
lesions histopathologically consistent with the non - fibrotic human syndrome termed 
follicular bronchiolitis (FB) (Myers and Colby 1993; Wells and du Bois 1993). Since 
CBAlJ mice develop similar foci of mononuclear cell organization, our studies reveal that 
BOOP lesions occur within a spectrum of inflammatory lung diseases that occur in the 
distal air spaces. Our studies with respiratory reovirus infection in different strains of mice 
suggest that genetic host factors are critical determinants of the degree of progression of a 
pulmonary insult from a primarily inflammatory response (FB) toward a fibrotic response 
(BOOP). 
Since infiltrating lymphocytes seem to be involved with the initiation of BOOP 
lesions (Mukae, et ai. 1995; Costabel, et al. 1992), it is possible that these cells play an 
active role in the progression of inflammatory foci into lesions which are progressively 
dominated by fibroblasts. The hyperplastic, reactive hilar lymphoid tissue and organizing 
lymphocytic peri-bronchiolar accumulations observed after reovirus infection suggest that a 
vigorous immune response is elicited in the lung and draining lymph nodes. We have 
previously demonstrated that the organizing lymphocytic peribronchiolar accumulations 
consisted of both CD4+ and CD8+ T lymphocytes, B lymphocytes, and increased numbers 
of macrophages in CD-l and Balb/c mice (Bellum, et al. 1996; Thompson, et al. 1996). In 
Balb/c mice, there is a dominance of CD8+ T lymphocytes in the lung interstitium and 
alveolar spaces after respiratory reovirus IlL infection (Thompson, et al. 1996). Lung and 
hilar lymph node lymphocyte populations contain virus-specific cytotoxic T lymphocytes 
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A comprehensive review of BOOP suggested that BOOP "is a nonspecific mode of 
repaIr of parenchymal structures after acute or subacute injury, and thus cannot be 
dissociated from the spectrum of inflammatory reactions that have both alveolar epithelial 
injury and fibrinous intra-alveolar deposition as a common denominator " (Cordier, et al. 
1994). These results describing the comparative differences in the respiratory response to 
reovirus infection among strains of mice are in agreement with this model. Thus, it is our 
contention that respiratory reovirus infection provides a small animal model to investigate 
the relationship of BOOP as a continuum of inflammatory lung disease. 
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CHAPTER 5 
Respiratory Reovirus l/L-Induced Acute Respiratory 
Distress Syndrome: A Model for the Study of the 





Acute respiratory distress syndrome (ARDS) is a significantly important acute lung 
disorder that is characterized by the most severe inflammatory reaction known to occur in 
the lungs (Luce 1998). The mortality rate exceeds 50% and generally ARDS is not 
responsive to corticosteroid treatment as is BOOP and currently only supportive therapy 
such as mechanical ventilation is available to treat ARDS (Rubin and Farber 1994). One of 
the most prominent pathological indicators of ARDS is the formation of hyaline membranes 
along the basal lamina between the vascular endothelium and the alveolar epithelium (Luce 
1998). The formation of these membranes results from the deposition of fibrin, albumin, 
cellular debris, and other material that is associated with widespread damage to the 
endothelial and epithelial surfaces (Luce 1998). The collapse of physical barriers between 
the intraluminal compartment of the alveoli and the vasculature leads to significant edema, 
which is a leading cause of mortality among ARDS cases (Luce 1998). Histopathological 
of observations of ARDS development in humans and in a rat model of ARDS demonstrate 
that the destruction of the vascular endothelium is preceded by damage to alveolar type I 
cells (Lamy 1976, Bachofen 1977). The pathogenesis of ARDS also includes infiltration of 
lymphocytes into the lung (Luce 1998). However, unlike BOOP and other lung disorders 
characterized by a foundation of organizing pneumonia with a patchy distribution in the 
lung, the distribution of infiltrating lymphocytes in ARDS is widespread (Luce 1998). 
The histopathological alterations that occur in the lung during the development of 
ARDS appear to be a generalized acute response to significant destruction of the alveolar 
epithelium. This suggestion is indicated by the observation that many of the common 
causes of ARDS, including sepsis syndrome (systemic bacterial infection), aspiration of 
gastric contents, pulmonary contusions, and near drownings all generate similar pulmonary 
pathological changes preceding ARDS (Hudson 1995). Currently one of the major 
obstacles in providing improved treatment modalities for ARDS is the lack of information 
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regarding the inflammatory cell populations that mediate the acute inflammatory response in 
the lung following alveolar epithelial cell damage (Baughman 1996). T -lymphocyte 
responses have long been observed to be associated with inflammatory responses in the 
lung, including ARDS, that are initiated by a wide variety of pathogenic, environmental, and 
autoimmune related causes (Kradin, et al. 1986; Costabel, et al. 1987; Hunninghake, et al. 
1980; DailI992). However, the role ofT-lymphoctes in acute inflammatory reactions in the 
lung have not been clearly defined (Kumar and Lykke 1995). Our laboratory has 
characterized a model of ARDS in CBAlJ mice following respiratory reovirus IlL infection. 
In this model approximately 40% of the infected animals develop an acute pulmonary 
inflammatory reaction during the second week of infection that recapitulates the 
histopathological features of ARDS described in humans. The mortality rate of CBAlJ 
mice that develop ARDS in this model is 100%. Those animals that do not develop ARDS 
survive and develop BOOP lesions. The contribution of T lymphocytes in the pathogenesis 
of ARDS in this model was examined by inducing a respiratory reovirus IlL infection in 
CBAlJ mice that were rendered T lymphocyte deficient by neonatal thymectomization. This 
approach demonstrated that none of the neonatally thymectomized (NTx) CBAlJ mice 
experienced an acute and deadly pulmonary inflammatory response to reovirus that is 
associated with ARDS. However, Ntx CBAlJ mice still developed-the intraluminal fibrosis 
that typifies BOOP lesion formation 
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RESULTS 
Respiratory reovirus tIL infection alternatively induces ARDS in a subset of 
CBAlJ mice 
Histological characterization was perfotmed on H&E stained fotmalin-fixed paraffin-
embedded lung sections from CBAlJ mice that died of ARDS related causes 12 days post 
reovirus IlL infection (Figure 5.1). The reovirus-induced pulmonary cellular infiltrate was 
chiefly composed of mononuclear cells and contained relatively few macrophages or 
PMNs. Overall, the cellular infiltrate was diffuse, but had demonstrated a degree of peri-
acinar organization (near bronchiolar divisions) (Figure 5.2A). Evidence of impaired 
circulation as a potential consequence of vascular damage included the observation of dense 
collections of compacted red blood cells (RBCs) (stained bright red) in the lung capillaries 
(Figure 5.2A). Higher magnification of the lung vasculature demonstrated the fotmation of 
hyaline membranes on damaged alveolar walls (Figure 5.2B). Typically hyaline membranes 
are composed of dead cellular debris and serum proteins like albumin that are all joined 
together in a fibrin matrix (Katzenstein, et ala 1976). Their presence is considered to be a 
hallmark histopathological feature of ARDS (Katzenstein and Askin 1990). 
ARDS development in CBA/J mice following reovirus inoculation is dose 
dependent 
Since an inoculum dose of 1 x 107 PFU of reovirus IlL resulted in a high mortality 
rate from ARDS in CBAlJ, we examined the effect of decreasing inoculum doses of 
reovirus IlL on the generation of BOOP lesions in additional experiments. In these studies 
we found that if a 1 log decrease in the viral inoculum dose was used, the percentage of 
CBAlJ mice that died from ARDS-related causes dropped from 90% to 40% (Table 5.1). 
All of the surviving mice still developed BOOP lesions that were indistinguishable from 
those observed in mice inoculated with 1 X 107 PFU. Mice inoculated with 1 X 105 PFU or 
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1 x 1()4 PFU of reovirus had a 100% survival rate but did not generate severe inflammatory 
lesions nor did they generate pronounced fibrotic BOOP lesions (Table 5.1). 
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Figure 5.1. Respiratory reovirus IlL infection induces ARDS in a subset of CBAlJ mice. 
H & E staining shows accumulation of mononuclear cells and PMNs in the interstitial 
and al v.eolar tiss.ue . 
UbJectIve magnltlcatIon, X 20. 
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Figure 5.2. Histologic characterization of acute respiratory distress syndrome (ARDS) in 
the subset of CBA/J mice that do not develop BOOP following respiratory reovirus I/L 
infection. H & E staining shows the over-accumulation of red blood cells (RBCs) in the 
capillaries of the lung (A, red staining). Higher magnification demonstrates the presence of 
proteinaceous edema in the vasculature (B, large arrow) and the development of thick 
hyaline membranes along the walls of the lung vasculature (B, small arrow). 
Objective magnification, X 10 (A) and X 20 (B). 
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Table I 







Histopathological characterization of the lungs of neonatally thymectomized 
CBAlJ mice following respiratory reovirus infection 
Confinnation of the T-Iymphocyte deficiency generated by neonatal thymectomy 
was obtained by utilizing flow cytometry analysis to compare the expression of the pan T-
cell surface marker, CD3, on peripheral lymphocytes (PLNs) isolated from NTx CBAlJ to 
the expression of CD3 on PLNs from nonnal age matched nonthymectomized CBAlJs 
(Figure 5.3). This analysis demonstrated that only 14 % of PLN lymphocytes from NTx 
CBAlJ mice were positive for CD3 as compared to the 69% of PLN lymphocytes that were 
positive for CD3 nonthymectomized CBAlJ mice (Figure 5.3). 
Histological observations of reovirus IlL infected or saline inoculated control NTx 
CBAlJ lungs were made on H&E stained paraffin embedded lung sections. By day 3 post 
reovirus inoculation, a mixed inflammatory infiltrate composed primarily of macrophages in 
addition to smaller subsets of polymorphonuclear (PMN) and mononuclear cells had 
gathered diffusely in the alveolar spaces and the interstitium of the lung (Figure 5.4B). In 
contrast, a cellular infiltrate was not observed in control lungs (Figure 5.4A). At day 7 post 
reovirus inoculation the cellular infiltrate had become less diffuse, ·and more organized 
around the bronchioles (Figure 5.4.C). The bronchoalveolar association of the cellular 
infiltrate became more noticeable at two weeks after reovirus inoculation (Figure 5.4D). 
Potential damage to the lung vasculature was also evident at two weeks after reovirus 
inoculation by the presence of edema in the alveolar spaces associated with the cellular 
infiltrate (Figure 5.4D, arrow). Higher magnification of the lesion two weeks after reovirus 
inoculation further revealed the thickening of alveolar walls, indicating alterations to the 
architecture of the lung (Figure 5.5A, large arrow). Additionally, at day 14 post reovirus 
infection fibrous polyps of collagenous tissue had developed in the alveolar spaces affected 
by the cellular infiltrate (Figure 5.5A, small arrow). As demonstrated in nonthymectomized 
CBAlJ mice the fibroblastic polyps in NTx CBAlJ mice could be observed in terminal 
bronchioles, alveolar ducts and alveoli. The continued development of these fibroblastic 
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polyps resulted in the formation of mature BOOP lesions by 21 after reovirus inoculation 
(Figure 5.5B). These BOOP lesions were patchily distributed in the lung and were 
associated with prominent clusters of intra-alveolar populations of foamy macrophages 




Figure 5.3. Flow cytometric analysis of splenic populations for the pa-T lymphocyte 
marker CD3 from normal and neonatally thymectomized (NTx) CBAlJ mice. 
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Figure 5.5. Histological characterization of BOOP in NTx CBAlJ mice. Day 14 after 
reovirus IlL infection (A). Day 21 after reovirus infection (B). 




appears to be dose dependent relationship since a ten-fold increase in the titer of the viral 
inoculum results in 90% of the CBAfJ mice developing ARDS and 10% developing BOOP. 
It is difficult to determine if those CBAfJ mice that develop ARDS following reovirus 
inoculation could also develop BOOP since edema, RBC congestion, and hyaline membrane 
formation precede BOOP lesion development by 2 to 3 days. It is during this interim that 
the CBAfJ mice that develop ARDS die of ARDS-related causes, before the time at which 
BOOP lesion formation is most likely to occur. It is possible, however, that ARDS 
represents a more acute form of the inflammatory reaction that results in the development of 
BOOP lesions. In humans histopathological observations of acute inflammatory responses 
in the lower respiratory tract suggest that ARDS is representative of a more severe form of 
the same type of inflammatory reaction that precedes BOOP formation (Wright, et al. 
1992). Generally, among those individuals that survive ARDS, most will also develop 
BOOP (Kuhn, et al. 1989). 
The participation of T-Iymphocytes in the development of the acute inflammatory 
reaction in the lungs of CBAfJ mice following respiratory reovirus infection is suggested by 
a marked reduction in the severity of the reovirus-induced pulmonary inflammatory 
response in T -lymphocyte-deficient neonatally thymectomized (NTx) CBAfJ mice. 
However, NTx CBAfJ mice still develop BOOP lesions following- reovirus infection, even 
though the reovirus-induced cellular infiltrate is dominated by macrophages and 
significantly less lymphocytic than observed in nonthymectomized CBAlJ mice following 
respiratory reovirus infection. These observations suggest the possibility that two separate 
components of the reovirus-induced inflammatory response can be identified in CBAlJ 
mice. The first aspect of the pulmonary inflammatory response to reovirus in CBAfJ mice 
could be a T-cell independent process that is primarily mediated by resident parenchymal 
cells and results in the development of intraluminal fibrotic lesions. A second component of 
the reovirus-induced pulmonary inflammatory response that is characterized by the 
development of ARDS may be a T-lymphocyte mediated progression of the inflammatory 
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Mechanisms that mediate the pathogenesis of inflammatory and fibrotic disorders of 
the bronchoalveolar compartment of the lungs remain ill-defined even though these 
disorders are becoming increasingly recognized as important secondary complications of 
connective tissue disorders, bone and lung transplantation, toxic fume exposure, and viral 
and bacterial infection (Epler 1992, Wright, et al. 1992, Wells and du Bois 1993, Myers and 
Colby 1993, Kanda, et al. 1997). Numerous observations of inflammatory diseases of the 
small airways by pathologists and morphologists have resulted in well-established 
histopathological descriptions of these disorders (Kuhn, et al. 1989, Wright, et al. 1992, 
Wells and du Bois 1993, Myers, et al. 1994). Such accounts of inflammation in the lung 
have resulted in the suggestion that many small airway inflammatory and fibrotic disorders 
belong to a continuum of lung disease, unified by a foundation of lymphocyte accumulation 
in the alveolar and interstitial compartments of the lung (Wright, et al. 1992, Myers and 
Colby 1993). However, the cellular and molecular events that orchestrate the regulation of 
pulmonary inflammation and fibrosis have not been well-delineated. The reovirus IIL-
induced model of respiratory inflammation strongly suggests that the genetic backgrounds 
of diffl!rent strains of mice contribute to the biological mechanisms that control the 
pulmonary inflammatory response to a single pathogenic agent. - In this model system 
respiratory reovirus-IlL infection can be used in CBAlJ mice to generate the acute small 
airway disorders BOOP and ARDS. In contrast, respiratory reovirus IlL infection of eD-
1, Balb/C, and C3H mice generates FB, a significantly less intense inflammatory reaction 
that is not accompanied by fibrosis or severe parenchymal cell damage. 
Several observations suggest that the variability in lung pathology among these 
mouse strains following reovirus infection is more related to the regulatory events of the 
inflammatory response to reovirus than to just simply the susceptibility of each strain to 
reovirus-mediated lytic cell damage. These include: (i) the titer of the inoculum of reovirus 
IlL used to infect CBAlJ mice (BOOP and ARDS) is ten-fold lower than that used to infect 
99 
CD-I, Balb/C, and C3H mice (FB); (ii) the clearance of infectious reovirus-IlL from the 
lungs CBAlJ mice and CD-l mice occurs with similar kinetics; and (iii) reovirus-IlL 
replication ceases in the lungs of CBAlJ mice and CD-l mice with similar kinetics. 
Normally, following injury to the alveolar epithelium, the lung generates proteolytic 
enzymes to reduce the presence of fibrin and other ECM proteins in the air spaces (Simon 
and Paine 1995). In particular, the activity of the urokinase-type plasminogen activator has 
been implicated as the major fibrinolytic factor in the lung (Idell S, et al. 1988, 1989; 
Bertozzi, et. al. 1990). In both animal models and in humans decreased activity of 
urokinase has been associated with the development of ARDS (Idell et al. 1989; Bertozzi et 
al. 1990). Therefore, it is possible that regulatory differences in ECM proteolytic 
mechanisms between CBAlJ mice and other mouse strains may also contribute to the acute 
pulmonary inflammatory response to reovirus in CBAlJ mice that is manifested by BOOP 
and ARDS. In the experimental model of interstitial lung inflammation and fibrosis 
induced by the toxic chematheraputic, bleomycin the lungs of C57BU6N mice (H-2b) are 
exquisitely sensitive to bleomycin and respond to both i.t. and i.v. administration of 
bleomycin with intense lung inflammation and interstitial fibrosis (Baecher-Allan and Barth 
1993). However, BALB/c mice (H-2d) are generally considered to be resistant to the 
inflammatory and fibrotic events occurring after bleomycin treatment (Janick-Buckner, et al. 
1989). The initial nuclear damage mediated by bleomycin to the bronchiolar and alveolar 
epithelium was equivalent in C57BU6N and BALB/c mice; however, C57BU6N mice 
demonstrated lower levels of hydrolase (enzyme that breaks down bleomycin) and increased 
levels of poly ADP-ribose polymerase (mediates cell damage by depleting NAD+) in 
comparison to BALB/c (Rossi, et al. 1987). These results are evidence of the strong role 
cellular enzymes may have in determining the susceptibility to pulmonary fibrosis. 
An association between expression of the murine major histocompatability complex 
(MHC) haplotype H-2b, which is expressed by C57BU6N mice, and acute lung 
inflammation and fibrosis has also been demonstrated in the bleomycin model (Janick-
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Buckner, et ale 1989). Whereas, mouse strains expressing H-2a, H-2d, and H-2k haplotypes 
are generally low responders to bleomycin. When the H-2 haplotype of a low responder 
strain like Balb/C is inserted to a high responder background like C57BU6N, there is 
considerable decrease in pulmonary fibrosis following i.t. bleomycin treatment (Rossi, et ale 
1987). Likewise the movement of a high responder H-2 haplotype to a low responder 
background can result in an increase in intensity of the fibrotic response to bleomycin 
(Rossi, et al. 1987). An analogous link between MHC background and an acute 
inflammatory response to respiratory reovirus infection was not demonstrated between 
CBAlJ and the other mouse strains screened with reovirus. The haplotype H-2k is shared 
by CBAlJ and C3H mice, yet in response to respiratory reovirus infection CBAlJ mice 
develop BOOP or ARDS, but the reovirus induced response in C3H mice is characterized 
by a relatively mild lymphocytic infiltration into the interstitial and alveolar spaces of the 
lung. 
In both clinical cases and in animal models, bleomycin induced lung injury is 
accompanied by an inflammatory infiltrate (Janick-Buckner, et ale 1989). The inflammatory 
infiltrate is typically characterized by PMNs and lymphocytes (Janick-Buckner, et ale 
1989). The infiltration of PMNs only occurs in the early stages of the response to 
bleomycin, but the lymphocytes persist throughout the fibrosis- (Janick-Buckner, et ale 
1989). Most of the lymphocytes are T cells and only 10% of the lymphocytes are B cells 
(Janick-Buckner, et al. 1989). When the bleomycin fibrosis model is moved from 
C57BU6 mice to outbred nude athymic C57BU6N mice, which lack a nonnal T-
lymphocyte component of the immune response, the reSUlting pulmonary fibrosis is similar 
between the normal and nude animals, which suggests that T -lymphocyte independent 
mechanisms may be involved in the pulmonary fibrotic process in response to bleomycin 
(Szapiel, et ale 1979). Also, in vivo antibody depletion of CD4+ or CD8+ popUlations does 
not appear to alter the course of pulmonary fibrosis in C57BU6J mice; however, the role of 
101 
T -lymphocytes in the tissue remodeling that occurs late in the fibrotic process has not been 
investigated (Janick-Buckner, et al. 1989). 
The prominence of infiltrating lymphocyte populations in the CD-l model of FB 
and of the CBAlJ model of BOOPf ARDS (Bellum, et a1. 1996, Bellum, et al. 1997) reflect 
the association of lymphocytic infiltrates with human FB, BOOP, and ARDS (Yousem, et 
al. 1985, Wright, et al. 1992, Kuhn, et al. 1989). T-Iymphocytes have also been identified 
as primary mediators of inflammation and fibrosis in models of interstitial pulmonary 
fibrosis (Suzuki, et al. 1996, Sharma, et al. 1996, Zhu, et al. 1996). In the lungs of T-
lymphocyte deficient NTx CBAlJ mice the reovirus-induced cellular infiltrate is not 
characterized by a prominent lymphocytic component, but is instead largely composed of 
macrophages and PMNs. Despite the decreased presence of T-Iymphocytes in the 
reovirus-induce inflammatory infiltrate Ntx CBAlJ mice continue to develop characteristic 
BOOP lesions, but do not develop the widespread vascular damage associated with ARDS. 
These observations suggest that the initiating event for BOOP and ARDS may be related to 
the reaction of the lung parenchyma to reovirus infection; however, the pathogenesis of 
ARDS may involve a T-lymphocyte mediated mechanism. 
Clearly, lung inflammation and fibrosis involves a complex network of interactions 
between a large number of cell types. Infection of resident pulmonary populations of cells 
by reovirus may initiate the production of a unique pattern of pro-inflammatory cytokines or 
non-peptide mediators which contribute to the characteristic pathologies observed in CBAlJ 
mice versus mouse strains that do not develop an acute pulmonary inflammatory response 
to reovirus IlL. Investigations utilizing reovirus IlL infection of mice will provide a model 
to systematically investigate the cellular and molecular mechanisms that lead to the 
development as well as the resolution of acute inflammatory diseases like BOOP and 
ARDS. Such studies are of significance not only for understanding the pathophysiology of 
FB, BOOP and ARDS, but are of broader significance since it is likely that a large 
proportion of inflammatory disorders of the distal regions of the lung exist undetected in 
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the population until they become symptomatic or life-threatening. Consequently, an 
improved understanding of the development and resolution of reovirus IlL-induced 
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